

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The COVID-19 pandemic: catching up with the... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-638/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-638" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The COVID-19 pandemic: catching up with the cataclysm" />
    
            <meta name="og:title" content="F1000Research Article: The COVID-19 pandemic: catching up with the cataclysm.">
            <meta name="og:description" content="Read the latest article version by Surajit Chakraborty, Anirban Basu, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="27540">
            <meta name="article-id" content="24963">
            <meta name="dc.title" content="The COVID-19 pandemic: catching up with the cataclysm">
            <meta name="dc.description" content="Infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the Coronaviridae family and is a positive-sense single-stranded RNA virus originating from Wuhan, China, was declared a global public health emergency on 11 March 2020. SARS-CoV-2 infection in humans is characterized by symptoms such as fever and dyspnea accompanied by infrequent incidence of lymphopenia, gastrointestinal complications such as elevated hepatic aminotransferases, and diarrhea. Originating in bats, the SARS-CoV-2 virus has been transmitted to humans likely via an intermediate host that is yet to be discovered. Owing to the absence of any vaccines or definite anti-viral drugs alongside the greater mobility of people across the globe, international and national efforts in containing and treating SARS-CoV-2 infection are experiencing severe difficulties. In this review, we have provided a picture of SARS-CoV-2 epidemiological characteristics, the clinical symptoms experienced by patients of varying age groups, the molecular virology of SARS-CoV-2, and the treatment regimens currently employed for fighting SARS-CoV-2 infection as well as their outcomes.">
            <meta name="dc.subject" content="SARS-CoV-2, Public health, Virus, Pandemic, COVID-19">
            <meta name="dc.creator" content="Chakraborty, Surajit">
            <meta name="dc.creator" content="Basu, Anirban">
            <meta name="dc.date" content="2020/06/23">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.24963.1">
            <meta name="dc.source" content="F1000Research 2020 9:638">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="SARS-CoV-2">
            <meta name="prism.keyword" content="Public health">
            <meta name="prism.keyword" content="Virus">
            <meta name="prism.keyword" content="Pandemic">
            <meta name="prism.keyword" content="COVID-19">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/06/23">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="638">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.24963.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-638">
            <meta name="citation_title" content="The COVID-19 pandemic: catching up with the cataclysm">
            <meta name="citation_abstract" content="Infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the Coronaviridae family and is a positive-sense single-stranded RNA virus originating from Wuhan, China, was declared a global public health emergency on 11 March 2020. SARS-CoV-2 infection in humans is characterized by symptoms such as fever and dyspnea accompanied by infrequent incidence of lymphopenia, gastrointestinal complications such as elevated hepatic aminotransferases, and diarrhea. Originating in bats, the SARS-CoV-2 virus has been transmitted to humans likely via an intermediate host that is yet to be discovered. Owing to the absence of any vaccines or definite anti-viral drugs alongside the greater mobility of people across the globe, international and national efforts in containing and treating SARS-CoV-2 infection are experiencing severe difficulties. In this review, we have provided a picture of SARS-CoV-2 epidemiological characteristics, the clinical symptoms experienced by patients of varying age groups, the molecular virology of SARS-CoV-2, and the treatment regimens currently employed for fighting SARS-CoV-2 infection as well as their outcomes.">
            <meta name="citation_description" content="Infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the Coronaviridae family and is a positive-sense single-stranded RNA virus originating from Wuhan, China, was declared a global public health emergency on 11 March 2020. SARS-CoV-2 infection in humans is characterized by symptoms such as fever and dyspnea accompanied by infrequent incidence of lymphopenia, gastrointestinal complications such as elevated hepatic aminotransferases, and diarrhea. Originating in bats, the SARS-CoV-2 virus has been transmitted to humans likely via an intermediate host that is yet to be discovered. Owing to the absence of any vaccines or definite anti-viral drugs alongside the greater mobility of people across the globe, international and national efforts in containing and treating SARS-CoV-2 infection are experiencing severe difficulties. In this review, we have provided a picture of SARS-CoV-2 epidemiological characteristics, the clinical symptoms experienced by patients of varying age groups, the molecular virology of SARS-CoV-2, and the treatment regimens currently employed for fighting SARS-CoV-2 infection as well as their outcomes.">
            <meta name="citation_keywords" content="SARS-CoV-2, Public health, Virus, Pandemic, COVID-19">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Surajit Chakraborty">
            <meta name="citation_author_institution" content="National Brain Research Centre, Manesar, Gurugram, Haryana, India">
            <meta name="citation_author" content="Anirban Basu">
            <meta name="citation_author_institution" content="National Brain Research Centre, Manesar, Gurugram, Haryana, India">
            <meta name="citation_publication_date" content="2020/06/23">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="638">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.24963.1">
            <meta name="citation_firstpage" content="638">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-638/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-638.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=27540 /> <input type=hidden id=articleId name=articleId value=24963 /> <input type=hidden id=xmlUrl value="/articles/9-638/v1/xml"/> <input type=hidden id=xmlFileName value="-9-638-v1.xml"> <input type=hidden id=article_uuid value=ed6ca138-9742-4ff5-a4a0-407ebe105c0a /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="The COVID-19 pandemic: catching up with the cataclysm"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.24963.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.24963.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-638"
  },
  "headline": "The COVID-19 pandemic: catching up with the cataclysm",
  "datePublished": "2020-06-23T17:07:42",
  "dateModified": "2020-06-23T17:07:42",
  "author": [
    {
      "@type": "Person",
      "name": "Surajit Chakraborty"
    },    {
      "@type": "Person",
      "name": "Anirban Basu"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the Coronaviridae family and is a positive-sense single-stranded RNA virus originating from Wuhan, China, was declared a global public health emergency on 11 March 2020. SARS-CoV-2 infection in humans is characterized by symptoms such as fever and dyspnea accompanied by infrequent incidence of lymphopenia, gastrointestinal complications such as elevated hepatic aminotransferases, and diarrhea. Originating in bats, the SARS-CoV-2 virus has been transmitted to humans likely via an intermediate host that is yet to be discovered. Owing to the absence of any vaccines or definite anti-viral drugs alongside the greater mobility of people across the globe, international and national efforts in containing and treating SARS-CoV-2 infection are experiencing severe difficulties. In this review, we have provided a picture of SARS-CoV-2 epidemiological characteristics, the clinical symptoms experienced by patients of varying age groups, the molecular virology of SARS-CoV-2, and the treatment regimens currently employed for fighting SARS-CoV-2 infection as well as their outcomes."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-638/v1",
            "name": "The COVID-19 pandemic: catching up with the cataclysm"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The COVID-19 pandemic: catching up with the cataclysm </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=27540 data-id=24963 data-downloads="" data-views="" data-scholar="10.12688/f1000research.24963.1" data-recommended="" data-doi="10.12688/f1000research.24963.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-638/v1/pdf?article_uuid=ed6ca138-9742-4ff5-a4a0-407ebe105c0a" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-24963-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-24963-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-24963-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Chakraborty S and Basu A. The COVID-19 pandemic: catching up with the cataclysm [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):638 (<a class=new-orange href="https://doi.org/10.12688/f1000research.24963.1" target=_blank>https://doi.org/10.12688/f1000research.24963.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-24963-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=24963 id=track-article-signin-24963 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/24963?target=/articles/9-638/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27540 /> <input name=articleId type=hidden value=24963 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The COVID-19 pandemic: catching up with the cataclysm</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:surajitchakraborty95@yahoo.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Surajit Chakraborty</span></a>,&nbsp;</span><span class=""><a href="mailto:anirban@nbrc.ac.in" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Anirban Basu</span></a><a href="https://orcid.org/0000-0002-5200-2054" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5200-2054</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:surajitchakraborty95@yahoo.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Surajit Chakraborty</span></a>,&nbsp;</span><span class=""><a href="mailto:anirban@nbrc.ac.in" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Anirban Basu</span></a><a href="http://orcid.org/0000-0002-5200-2054" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5200-2054</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 23 Jun 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.24963.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> National Brain Research Centre, Manesar, Gurugram, Haryana, India<br/> <p> <div class=margin-bottom> Surajit Chakraborty <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Resources, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Anirban Basu <br/> <span>Roles: </span> Conceptualization, Investigation, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=69708-65153></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=69709-65154></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the Coronaviridae family and is a positive-sense single-stranded RNA virus originating from Wuhan, China, was declared a global public health emergency on 11 March 2020. SARS-CoV-2 infection in humans is characterized by symptoms such as fever and dyspnea accompanied by infrequent incidence of lymphopenia, gastrointestinal complications such as elevated hepatic aminotransferases, and diarrhea. Originating in bats, the SARS-CoV-2 virus has been transmitted to humans likely via an intermediate host that is yet to be discovered. Owing to the absence of any vaccines or definite anti-viral drugs alongside the greater mobility of people across the globe, international and national efforts in containing and treating SARS-CoV-2 infection are experiencing severe difficulties. In this review, we have provided a picture of SARS-CoV-2 epidemiological characteristics, the clinical symptoms experienced by patients of varying age groups, the molecular virology of SARS-CoV-2, and the treatment regimens currently employed for fighting SARS-CoV-2 infection as well as their outcomes. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> SARS-CoV-2, Public health, Virus, Pandemic, COVID-19 </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Surajit Chakraborty (<a href="mailto:surajitchakraborty95@yahoo.com">surajitchakraborty95@yahoo.com</a>) <br> Anirban Basu (<a href="mailto:anirban@nbrc.ac.in">anirban@nbrc.ac.in</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Surajit Chakraborty, Anirban Basu </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Chakraborty S and Basu A. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Chakraborty S and Basu A. The COVID-19 pandemic: catching up with the cataclysm [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):638 (<a href="https://doi.org/10.12688/f1000research.24963.1" target=_blank>https://doi.org/10.12688/f1000research.24963.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 23 Jun 2020, <b>9</b>(F1000 Faculty Rev):638 (<a href="https://doi.org/10.12688/f1000research.24963.1" target=_blank>https://doi.org/10.12688/f1000research.24963.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 23 Jun 2020, <b>9</b>(F1000 Faculty Rev):638 (<a href="https://doi.org/10.12688/f1000research.24963.1" target=_blank>https://doi.org/10.12688/f1000research.24963.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d11369e153>Introduction</h2><p class="" id=d11369e156>Following the emergence of atypical pneumonia in Guangdong province in 2002–2003, scientific investigators in Hong Kong discovered severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent. SARS-CoV spread across the globe, infecting approximately 800 people with a case fatality rate of about 10%. Infection by SARS-CoV was accompanied by symptoms such as fever, coughing, and respiratory distress often leading to pneumonic changes in the lungs<sup><a href="#ref-1">1</a></sup>. Around 2011–2012, the world experienced the emergence of another coronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV). Upon infection by the latter, patients demonstrated symptoms and CT findings similar to those seen in the SARS-CoV outbreak<sup><a href="#ref-2">2</a></sup>. Although MERS-CoV exhibited a greater case fatality rate than did SARS-CoV, human-to-human transmission was seldom observed. Here, we review the current findings regarding the emergence of the novel coronavirus (SARS-CoV-2) in Wuhan, China, in 2019, its origin, epidemiology, plethora of associated clinical findings, and molecular virology, and the therapeutic strategies being subjected to investigation to combat the global health emergency triggered by this virus.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11369e170>Origin and epidemiology</h2><p class="" id=d11369e173>Since 2019, infection by SARS-CoV-2, which belongs to the Coronaviridae family, has resulted in an international global health issue. As of 28 March 2020, according to a World Health Organization report, 512,701 people globally have been infected, resulting in 23,495 deaths. Following the emergence of pneumonia-like cases of unknown origin in Wuhan, Hubei Province, China, deep sequencing analysis from patients’ lower respiratory tract samples revealed the cause of illness as a novel betacoronavirus, 2019-nCoV. Further analysis of genomes sequenced from the bronchoalveolar lavage (BAL) fluid of nine patients revealed that the genome of the causative agent bears about 79% and 50% similarity to SARS-CoV and MERS-CoV, respectively<sup><a href="#ref-3">3</a></sup>. On the other hand, maximum sequence similarity was observed with the bat coronaviruses bat-SL-CoVZC45 and bat-CoVZXC21 (87.99% and 87.23%, respectively). The eight complete genomes of 2019-nCoV isolated displayed about 99.98% sequence identity with each other, thus pointing to its very recent emergence in the human population. Work by Yuen and colleagues also demonstrated that 2019-nCoV genomes exhibit greatest similarity with bat SARS-like coronaviruses bat-SL-CoVZC45 and bat-CoVZXC21<sup><a href="#ref-4">4</a></sup>. Although the origin of the 2019-nCoV has been traced to bats, reports point towards the possibility of pangolins as a probable origin for SARS-CoV-2<sup><a href="#ref-5">5</a></sup>. Not only does the pangolin-CoV possess 91.02% similarity with 2019-nCoV at the whole genome level but also five critical amino acids of the S1 domain of 2019-nCoV spike (S) protein were found to be conserved in pangolin-CoV. The authors suggested possible divergence of pangolin SARS-CoV into two distinct lineages, one capable of infecting bats (RaTG13) and the other humans (SARS-CoV-2). Comparison of similarities in nucleotide sequence and S protein receptor-binding domain amongst RaTG13, SARS-CoV-2, and pangolin SARS-CoV led to the formulation of this divergence theory pointing towards the role of pangolin SARS-CoV as the probable closest common ancestor to RaTG13 and SARS-CoV-2. However, the authors did not provide any hint indicating the chance of emergence of SARS-CoV-2 directly from pangolin SARS-CoV-2. A study by Liu <i>et al</i>.<sup><a href="#ref-6">6</a></sup>, however, pointed directly to the fact that SARS-CoV-2 did not evolve directly from pangolin SARS-CoV on the basis of S-gene nucleotide sequence comparison amongst bat coronavirus, pangolin SARS-CoV, and SARS-CoV-2. The authors also support the view that SARS-CoV-2 originated via multiple recombination events in nature whose exact sequence determination will necessitate further investigations. In addition to the theory that natural selection acted upon 2019-nCoV in an animal host prior to zoonotic transfer, the possibility of natural selection in humans post-zoonotic transfer has been opined by some<sup><a href="#ref-7">7</a></sup>. It might also be possible that the SARS-CoV-2 progenitor, while undergoing transmission in humans following zoonotic transfer, acquired genomic features necessary for the pandemic to take off.</p><p class="" id=d11369e200>Li <i>et al.</i><sup><a href="#ref-8">8</a></sup> describe the epidemiological characteristics of nCoV-induced pneumonia (NCIP) by studying the demographic information, exposure history, and illness timelines of confirmed cases of SARS-CoV-2 reported by 22 January 2020. In brief, the median age of patients confirmed with NCIP was 59 years. A total of 55% of the NCIP cases reported before 1 January 2020 were found to be directly associated with a visit to the Huanan seafood wholesale market in contrast to very few (8.6%) of the subsequent cases, thus providing evidence of human-to-human transmission occurring among close contacts. The mean incubation period was found to be 5.2 days, with the 95<sup>th</sup> percentile of distribution at 12.5 days. During this early period of outbreak, using the mean serial interval, which was calculated to be 7.5 days, the reproductive number was estimated to be 2.2. The SARS-CoV-2 outbreak, with its epicenter in Wuhan, was demonstrated to result in a possible nosocomial spread and beyond Wuhan<sup><a href="#ref-4">4</a></sup>. Patients, after contracting the virus in Wuhan, were found to travel to Shenzhen, thus infecting those who did not have any history of travelling to Wuhan. This study was also the first to identify an asymptomatic male patient (10 years old) whose lung CT scan presented with “ground-glass opacity” pneumonic changes. Subsequent to the spread of the virus within Wuhan and outside, reports began to emerge suggesting the spread of the virus beyond Chinese national boundaries. Observations published suggested the spread of the SARS-CoV-2 virus outside China to Taiwan<sup><a href="#ref-9">9</a></sup> and the United States<sup><a href="#ref-10">10</a></sup>. Another study by Sun <i>et al.</i><sup><a href="#ref-11">11</a></sup> reported the epidemiological profile of the SARS-CoV-2 infection of 507 patients from mainland China as well as exported cases on the basis of a crowdsource platform (from 13 to 31 January 2020). The age distribution of SARS-CoV-2 patients displayed a skew towards older age groups, with a median age of 45 years. The median age of the patients who had died during reporting was observed to be 70 years, thus indicating that older age groups are at greater risk of poor outcomes. The relative risk measurement for the age group below 15 years was found to be significantly low, i.e. 0.5. A report by Wu <i>et al.</i><sup><a href="#ref-12">12</a></sup> provided an estimation of the clinical severity of SARS-CoV-2 infection based upon data up to 28 February 2020. The authors used a transmission dynamics model updated with real-time input data and data from additional sources to predict symptomatic case fatality risk (sCFR), the relative susceptibility to symptomatic infection on the basis of different age groups. Overall, the sCFR in Wuhan was found to be 1.4% (0.9–2.1%). When the sCFR was analyzed on the basis of different age groups, it was found to be 0.3%, 0.5%, and 2.6% for &lt;30 years, 30–59 years, and &gt;59 years, respectively. The age groups &lt;30 years and &gt;59 years were found to be 0.16 and 2.0 times more susceptible to symptomatic infections, respectively. In addition to these clinical severity measures, the basic reproduction number and mean serial interval were observed to be 1.94 (1.82–2.06) and 7.0 (5.8–8.1) days, respectively. However, it should be kept in mind that the basic reproductive number varies widely depending upon socio-economic, behavioral, biological, and environmental factors and hence must be interpreted with deep caution<sup><a href="#ref-13">13</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11369e244>Molecular virology: genome characteristics, spike protein structure, and its implication in human ACE2 receptor binding</h2><p class="" id=d11369e247>Coronaviruses comprise a group of viruses whose infection is characterized by signs and symptoms such as fever, respiratory distress, gastrointestinal complications, etc. The genomes of coronaviruses range from 26 to 32 Kb and consist of 6 to 11 open reading frames (ORFs)<sup><a href="#ref-14">14</a></sup>. The first ORF, which comprises up to nearly 67% of the entire genome, codes for 16 non-structural proteins (nsps)<sup><a href="#ref-15">15</a></sup>. On the other hand, the remaining ORFs code for accessory and four structural proteins, namely matrix (M), S, envelope (E), and nucleocapsid (N) proteins. A study published by Lu <i>et al.</i><sup><a href="#ref-3">3</a></sup> provided one of the first reports stating the characteristics of the SARS-CoV-2 genome and the putative human receptor utilized for its entry. Whole genome sequencing followed by comparison revealed 87.99% and 87.23% sequence similarity with SARS-like bat coronaviruses bat-SL-CoVZC45 and bat-SL-CoVZXC21, respectively, which was found to be significantly greater than its similarity with SARS-CoV and MERS-CoV (79% and 50%, respectively). Comparison of the predicted coding regions of 2019-nCoV with bat-SL-CoVZC45 and bat-SL-CoVZXC21 revealed similar genome organization and 12 predicted coding regions (1ab, S, 3, E, M, 7, 8, 9, 10b, N, 13, and 14). The lengths of most proteins encoded by 2019-nCoV were found to be similar to those of bat SARS-like coronaviruses, with only a few minor modifications. The S protein of 2019-nCoV was found to be longer than that of bat SARS-like coronaviruses, SARS-CoV, and MERS-CoV. Although the 2019-nCov S protein possesses 76.2% sequence similarity with that of SARS-CoV, S1 domain of 2019-nCoV possesses 50 amino acids which were found to be conserved in S1 domain of SARS-CoV. Even gene sequence comparison revealed a greater similarity between 2019-nCoV receptor binding domain of S protein and SARS-CoV than bat-SARS-like coronaviruses. Analysis of the 2019-nCoV genome by another group<sup><a href="#ref-16">16</a></sup> suggested 14 ORFs encoding for 27 proteins. Genes comprising ORF1ab and 1a were observed to be located at the 5' terminus, thus encoding pp1ab and pp1a proteins, respectively. Together, pp1ab and pp1a encode 15 nsps including nsp1 to nsp10 and nsp12 through nsp16. The 3' terminus was found to harbor genes for S, E, M, N, and eight accessory proteins (3a, 3b, p6, 7a, 7b, 8b, 9b, and orf14). As documented by Lu <i>et al.</i>, the protein sequence of 2019-nCoV was found to be similar when compared to SARS-CoV<sup><a href="#ref-16">16</a></sup>, although certain differences were observed and deserve special mention. The accessory protein 8a found in SARS-CoV was not present in 2019-nCov. The 8b protein of 2019-nCov was found to be larger (124 amino acids) than that of SARS-CoV (84 amino acids). On the contrary, 2019-nCoV protein 3b was discovered to significantly differ in length (22 amino acids) to that of SARS-CoV (154 amino acids). Combined, 380 amino acid substitutions were found in 2019-nCoV and the respective protein sequences of SARS-CoV and bat-SARS-like coronaviruses. However, no amino acid sequence differences were observed for proteins like nsp7, nsp13, E, M, p6, and 8B. Further research investigating the significance of the differences in amino acid sequence thus might provide insight into the differences in host selection, transmissibility, tropism, and pathogenicity.</p><p class="" id=d11369e276>Coronaviruses use S protein for entry to target cells. S protein consists of two functional subunits, S1 and S2. The S1 subunit contributes to receptor binding followed by the fusion of host cell endosomal membrane with viral envelope aided by S2 subunit. Following interaction of the S1 subunit with the cellular receptor, host-derived proteases are known to cleave at the S1/S2 and S2' junctions, resulting in a series of irreversible conformational changes, hence culminating into nucleocapsid entry<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>. One of the notable features of the 2019-nCoV S protein is a polybasic Q<sub>677</sub>TNSPRRARSV<sub>687</sub> site situated at the S1/S2 junction<sup><a href="#ref-7">7</a></sup>. Numerous such polybasic sites were found in the S protein sequence of multiple highly pathogenic avian influenza viruses<sup><a href="#ref-20">20</a></sup>, which upon abrogation culminated in the amelioration of their pathogenicity. However, upon mutation of the furin-mediated cleavage site within the aforementioned sequence, SARS-CoV-2-mediated entry into Vero and human angiotensin-converting enzyme 2 (hACE2)-expressing cells was moderately affected, hence indicating its possible role in virus tropism and transmissibility. As suggested by Andersen <i>et al.</i><sup><a href="#ref-7">7</a></sup>, the incorporation of proline into the polybasic site might result in the addition of O-linked glycans flanking the cleavage site, thus helping to form mucin-like domains, which in turn can shield epitopes or key residues in the 2019-nCoV S protein<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d11369e311>Phylogenetic analysis of the receptor-binding domain of four different lineages of coronaviruses revealed a closer relationship between 2019-nCoV and SARS-CoV than with bat-SL-CoVZC45 and bat-SL-CoVZXC21, despite high similarity of 2019-nCoV with the latter two at the whole genomic level<sup><a href="#ref-3">3</a></sup>. In addition, since 76% similarity was obtained at the level of amino acid sequence of S protein of 2019-nCoV and SARS-CoV, the role of the hACE2 protein (which was reported to act as the receptor for SARS-CoV) as a putative receptor for 2019-nCoV was subjected to intensive analysis. A study by Zhou <i>et al.</i><sup><a href="#ref-22">22</a></sup> provided the first evidence for the role of ACE2 as the cellular entry receptor for 2019-nCoV. Infection of HeLa cells expressing hACE2 protein resulted in infection by 2019-nCoV, which was found to be reversed in the absence of hACE2, thus proving that hACE2 indeed plays a role in the entry of 2019-nCoV. Moreover, this study also showed that 2019-nCoV does not use other coronavirus receptors like aminopeptidase N (APN) and dipeptidyl peptidase 4 (DPP4) for its entry into host cells. In agreement with previous findings, a report by Hoffmann <i>et al.</i><sup><a href="#ref-23">23</a></sup> also supported the role of hACE2 as the entry receptor protein for 2019-nCoV. Directed expression of hACE2 protein or bat ACE2 resulted in infection of non-susceptible BHK-21 cells by 2019-nCoV. In addition to the role of human ACE2 protein in viral entry, the report also mentioned the role of endosomal proteases cathepsins B and L and serine protease TMPRSS2 in the priming of S protein for 2019-nCoV entry. Ammonium chloride-mediated failure in acidifying the endosomes resulted in inhibition of SARS-CoV-2 S-mediated viral entry, pointing towards a role for cathepsins B and L. The clinically proven TMPRSS2 inhibitor camostat mesylate was also demonstrated to inhibit viral entry mediated by 2019-nCoV S protein. Full inhibition of S protein-induced viral entry was reported when camostat mesylate and E-64d and an inhibitor of cathepsin B/L were added together, thus revealing a cohesive role for TMPRSS2 and cathepsin B/L in S protein priming and viral entry.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11369e333>Spectra of clinical characteristics in patients suffering from 2019-nCoV infection</h2><p class="" id=d11369e336>The battery of clinical manifestations upon infection by SARS-CoV-2 infection ranges from common symptoms like fever, cough, and myalgia to infrequently reported rhinorrhea, confusion, dizziness, vomiting, and diarrhea (<a href="#f1">Figure 1a</a>). A study published by Huang <i>et al.</i><sup><a href="#ref-24">24</a></sup> reported that most patients present with fever, dry cough, dyspnea, and ground-glass opacity on chest CT scans, resembling the clinical features documented in SARS-CoV and MERS-CoV infections<sup><a href="#ref-2">2</a>,<a href="#ref-25">25</a></sup>. Very few patients also presented with the same for upper respiratory tract infections like sneezing, sore throat, and rhinorrhea. However, less common symptoms like headache, hemoptysis, and diarrhea were also observed in a few of the patients from the cohort. Unlike SARS-CoV and MERS-CoV infections presenting with gastrointestinal complications like diarrhea, vomiting in 20–25% of cases<sup><a href="#ref-2">2</a>,<a href="#ref-25">25</a></sup>, the aforementioned study also demonstrated that only 8% of the cohort experienced diarrhea. Biochemical analysis demonstrated increased plasma IL1B, IL1RA, IL-7, IL-8, IL-9, IL-10, basic FGF, GCSF, GMCSF, interferon (IFN)-γ, IP-10, MCP-1, MIP-1A, MIP-1B, PDGF, TNF-α, and VEGF concentrations compared to healthy adults. In addition, ICU-admitted patients exhibited higher plasma abundance of IL-2, IL-7, IL-10, GCSG, IP-10, MCP-1, and TNF-α than did non-ICU-admitted patients. Thus, 2019-nCOV patients were shown to demonstrate activation of both Th1 and Th2 arms of immunity, which differs from other SARS-CoV infections<sup><a href="#ref-26">26</a></sup>. In agreement with the previous report, Chen <i>et al.</i><sup><a href="#ref-27">27</a></sup> also reported a greater prevalence of common signs and symptoms like fever, dry cough, and dyspnea compared to less common symptoms like muscle ache, confusion, headache, nausea, vomiting, and diarrhea. Elevated serum alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, and lymphopenia were observed in a substantial number of patients, as shown by Huang <i>et al.</i><sup><a href="#ref-24">24</a></sup>. Although elevated hepatic aminotransferases in the blood of 2019-nCoV patients may indicate acute liver injury via viral hepatitis, Bangash <i>et al.</i><sup><a href="#ref-28">28</a></sup> suggested that the elevation of aminotransferase concentration may arise as a result of altered immune interactions involving hepatic cytotoxic T-cells and Kupffer cells. A report explaining radiological findings from 2019-nCoV patients<sup><a href="#ref-29">29</a></sup> provides a detailed account of pulmonary architecture upon 2019-nCoV infection. The mean number of lung segments involved was observed to be 10.5. A predilection was observed for right lower lobes, which is probably attributed to the short and straight anatomical structure of the right bronchus. CT scans of patients with subclinical illness exhibited unilateral involvement with multifocal ground-glass opacities. During the first week of symptom appearance, bilateral involvement was noticed. The lesion was diffuse in nature with a reduction in the frequency of ground-glass opacity, followed by transition to consolidation and mixed-pattern development during the second week post-symptom onset. Interlobular or interseptal thickening was noted, suggesting a resemblance to CT findings from SARS-CoV<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup> and MERS-CoV infections<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. The authors also proposed a positive correlation between NCIP and old age as well as comorbidities such as chronic obstructive pulmonary disease, diabetes, and other chronic pathological states. Multiple reports highlighting the cardiac perturbations observed in the context of SARS-CoV-2 infection are currently emerging. A study by Inciardi <i>et al.</i><sup><a href="#ref-37">34</a></sup> documented a case study of a 53-year-old female patient where SARS-CoV-2 infection was observed to be associated with multiple cardiac complications. The patient’s left ventricular wall exhibited an increase in thickness, diastolic impairment, reduced ejection fraction, and circumferential pericarditis. Another report by Creel-Bulos <i>et al.</i><sup><a href="#ref-35">35</a></sup> reported incidences of acute cor pulmonale in patients suffering from SARS-CoV-2 infection. The complication was associated with right ventricular dilatation with systolic impairment and presence of pulmonary thromboembolism. Although SARS-CoV-2 has been hypothesized to be able to infect cardiomyocytes owing to their high expression of ACE2 and incidences of coagulopathy in COVID-19, further studies are necessary before concluding that there is any causative relationship between SARS-CoV-2 infection and cardiological malfunctions.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/27540/832d838f-b14f-44ba-b83e-fe29a697086c_figure1.gif"><img alt="832d838f-b14f-44ba-b83e-fe29a697086c_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/27540/832d838f-b14f-44ba-b83e-fe29a697086c_figure1.gif"></a><div class=caption><h3>Figure 1. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2-induced clinical symptoms and the mechanistic basis culminating in infection-induced cytokine storm.</h3><p id=d11369e426>Figure 1a depicts the major organ systems affected in the course of SARS-CoV-2 infection in patients. The involvement of pulmonary, cardiovascular, renal, and nervous systems observed in patients has been shown in the figure with major clinical findings related to respective organ dysfunction. Figure 1b elucidates the mechanistic basis for pulmonary immunopathology associated with SARS-CoV-2 infection. Owing to infection of alveolar pneumocytes by SARS-CoV-2, cells undergo pyroptosis, upon which chemicals like ATP molecules, ASC oligomers, and viral RNA are released. These chemicals play a major role in activating alveolar macrophages. Alveolar macrophages, upon activation, result in the synthesis and secretion of a battery of chemokines and cytokines into the interstitial space. Chemokines promote the extravasation of granulocytes and lymphocytes into the lung parenchyma to help combat the infection. Macrophages and neutrophils secrete proinflammatory mediators such as interleukin (IL)-1, IL-6, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1, interferon gamma (IFN-γ)-induced protein 10 (IP-10), and tumor necrosis factor (TNF)-α, thus activating adaptive immune cells (such as T-helper cells, etc.) and natural killer (NK) cells to secrete IFN-γ, which in turn stimulates neutrophils and macrophages to secrete IL-1, IL-6, MCP-1, MIP-1, IP-10, and TNF-α. This vicious cycle of inflammation culminates in unwanted tissue damage, resulting in the pulmonary pathology observed in COVID-19.</p></div></div><p class="" id=d11369e433>Helms <i>et al</i>.<sup><a href="#ref-36">36</a></sup> reported neurological features of 58 patients suffering from COVID-19. A total of 84% of the patients exhibited neurological features like agitation and confusion, corticospinal tract signs (hyperreflexia), leptomeningeal space enlargement, and bilateral frontotemporal hypoperfusion. However, not all signs and symptoms were being noticed together in any particular individual patients. Few patients upon magnetic resonance imaging (MRI) were observed to have experienced acute/sub-acute ischemic stroke. A similar report by Mao <i>et al.</i><sup><a href="#ref-37">37</a></sup><i></i> documented a case series and the neurological features associated with SARS-CoV-2 infection based upon patients’ subjective descriptions. Neurologic complications including cerebrovascular disease, conscious disturbance, and skeletal muscle injury were observed in 36.4% of patients. The prevalence of taste and smell disorders was also observed in a minority (5%) of patients. Incidences of loss of smell and/or taste were also demonstrated by Bénézit <i>et al.</i><sup><a href="#ref-38">38</a></sup> in a retrospective study of data collected using a web-based questionnaire. Hypogeusia and hyposmia were found to be strongly correlated with COVID-19 both separately and in a combined fashion. Since the nervous system possesses ACE2 receptors, exposure of the olfactory epithelium to the virus may help contribute to the manifestations described above. In agreement with the notion that SARS-CoV-2 possesses neuroinvasive potential, a case study reported by Moriguchi <i>et al.</i><sup><a href="#ref-39">39</a></sup> described the neurological findings of a 24-year-old male patient upon infection by SARS-CoV-2. Viral RNA was detected in the cerebrospinal fluid (CSF). The patient was found in an unconscious state and was observed to experience transient generalized seizure during transit to the hospital. Imaging resulted in the discovery of right lateral ventriculitis, right medial temporal lobe encephalitis, and hippocampal atrophy. Further reports mentioning neurological symptoms and imaging findings will help understand the dynamic spectra of manifestations. Investigations using animal models to elucidate neuroinvasive mechanisms will further help unfold SARS-CoV-2 biology, thus providing significant insights for the development of future therapeutic strategies.</p><p class="" id=d11369e463>In accordance with the previous study, results stated by Yang <i>et al.</i><sup><a href="#ref-40">40</a></sup> similarly showed a positive correlation among old age, comorbidities like diabetes, and 2019-nCoV infection-induced death. Out of the 52 critically ill patients enrolled for the study (mean age: 59.7 years), 32 patients died, resulting in a mortality rate of 61.5%. The mean age of survivors was also found to be less when compared to that of non-survivors (51.9 years versus 64.6, respectively), thus indicating a poor outcome of infection in critically ill patients with greater age. Analysis of upper respiratory specimens of infected patients (age ranging from 26–76 years) revealed higher viral loads with onset of symptoms followed by a gradual decline with the progression of time<sup><a href="#ref-41">41</a></sup>. Moreover, viral load found in the nasal passageway was greater than in the throat, which resembles that of influenza<sup><a href="#ref-42">42</a></sup> but not of SARS-CoV infection<sup><a href="#ref-43">43</a></sup>. Besides the prevalence of co-morbid conditions (such as diabetes mellitus and hypertension), the other determining factors deciding increased mortality of elderly COVID-19 patients are still under investigation. However, altered pulmonary dendritic cell maturation and T-cell activation might contribute to amplified immune reaction in the lungs, resulting in increased mortality<sup><a href="#ref-44">44</a></sup>. Based upon the future demographic scenario according to the World Health Organization, which predicts the population size above the age of 65 years to be almost double that under 5 years of age, the effect of SARS-CoV-2 infection on elderly patients underscores the importance of elucidating the mechanistic differences in the immune response and thus pathology in elderly and non-elderly patient groups<sup><a href="#ref-45">45</a></sup>.</p><p class="" id=d11369e494>Lu <i>et al.</i><sup><a href="#ref-46">46</a></sup> provide evidence for infection in children being accompanied by a milder clinical course when compared to that in adults. Lymphopenia was observed in 3.5% of children (6 out of 171). In addition to fever, the other common signs and symptoms included cough and pharyngeal erythema. A similar study by Liu <i>et al.</i><sup><a href="#ref-47">47</a></sup> also points towards lymphopenia observed in children infected with 2019-nCoV. Lesser severity of clinical symptoms in pediatric patients when compared to adults has also been demonstrated by Xu <i>et al.</i><sup><a href="#ref-48">48</a></sup>. Although fewer cases of lymphopenia, leukopenia, or elevated transaminases were observed than in adults, rectal swabs of 8 out of 10 patients were found to be positive for viral RNA as quantified by real-time RT-PCR. Shedding of viral RNA was found to continue even after viral RNA became undetectable in nasopharyngeal swabs. Qui <i>et al</i>.<sup><a href="#ref-49">49</a></sup> published a study in concordance with the aforementioned ones, demonstrating less severe signs, symptoms, and laboratory findings in pediatric patients with a mean age of 8.3 years. A large proportion of asymptomatic patients were observed, thus highlighting the implication of the latter upon controlling disease spread. However, multiple recent reports of pediatric COVID-19 cases point towards variable disease severity, signs, and symptoms. A report by Pain <i>et al.</i><sup><a href="#ref-50">50</a></sup> documented an atypical case of a 14-year-old COVID-19 pediatric patient presenting without respiratory distress. Gradually, the patient developed symptoms like lymphopenia, increased D-dimer, elevation of serum ALT and AST, dyspnea, and cytokine storm. Upon treatment with the IL-1 inhibitor anakinra, conditions were found to improve followed by the absence of viral RNA in nasopharyngeal samples and stool. Similar findings were reported by Dallan <i>et al.</i><sup><a href="#ref-51">51</a></sup>, where adolescent patients with an age ranging from 10–12 years were found to present with hypotensive shock, compensated shock with cold periphery and late capillary filling time, and multi-organ dysfunction syndrome (MODS). Transmission of SARS-CoV-2 in premature infants has also been documented to be associated with elevation of serum inflammatory markers, respiratory distress, and MODS (associated with renal, liver, and bone marrow dysfunction)<sup><a href="#ref-52">52</a></sup>. Administration of the IL-6 inhibitor tocilizumab and remdesivir eventually resulted in the restoration of respiratory physiology and improvement of organ functions. These studies thus highlight the variability of signs and symptoms presented by pediatric COVID-19 patients and its significance in the early and proper diagnosis of these patients in order to avoid poor disease outcomes.</p><p class="" id=d11369e539>Data published by Chen <i>et al.</i><sup><a href="#ref-53">53</a></sup> evaluated the clinical characteristics and risk for intrauterine vertical transmission of SARS-CoV-2 in pregnant women undergoing Cesarean section. No differences in clinical characteristics were observed in pregnant patients with respect to non-pregnant adults. Chest CT scans revealed multifocal bilateral ground-glass opacity. Common symptoms exhibited by patients consisted of fever and cough, whereas the less common ones were sore throat, myalgia, malaise, diarrhea, and shortness of breath. Similar evidence was also provided by Li <i>et al.</i><sup><a href="#ref-54">54</a></sup>, stating that clinical manifestations of pregnant women upon 2019-nCoV infection did not differ from those of non-pregnant adults. Chen <i>et al</i>.<sup><a href="#ref-53">53</a></sup> showed no vertical transmission of virus, as demonstrated by the absence of viral RNA in amniotic fluid, cord blood, and neonatal throat swab. Although one out of seven neonates tested positive for viral RNA on throat swab 36 hours after birth<sup><a href="#ref-54">54</a></sup>, the placenta and cord blood were found to be negative for 2019-nCoV RNA, thus warranting further investigation to determine intrauterine vertical transfer.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11369e569>General pathology and immunopathogenesis</h2><p class="" id=d11369e572>Multiple autopsy reports of patients suffering from COVID-19 have surfaced, providing a vivid description of the pathology associated with infection with SARS-CoV-2<sup><a href="#ref-55">55</a>–<a href="#ref-57">57</a></sup>. Reported findings of autopsy examination of deceased COVID-19 patients revealed incidences of pulmonary embolism and reticular infiltration of lungs with bilateral diffuse ground-glass opacity on CT scans. Pulmonary interstitium appeared to be heavy and firm upon gross examination. Examination of cut surfaces of lung tissue exhibited alternate areas of tan-gray consolidation with patchy hemorrhagic areas. Histological analyses of pulmonary tissue indicated activated pneumocytes, microvascular thrombosis, capillary congestion due to deposition of fibrin thrombi, alveolar basement membrane edema, alveolar septum degeneration, and hyaline membrane deposition, thus culminating in ventilation-perfusion mismatch. In addition, both granulocytic and lymphocytic infiltration was observed in the pulmonary interstitium. Incidences of deep vein thrombosis were also noted in a significant proportion of patients. The presence of CD61<sup>+</sup> megakaryocytes with nuclear hyperchromasia and atypia were also denoted by autopsy findings. Entrapment of neutrophils in fibers deposited in the pulmonary interstitium indicate a role for neutrophil extracellular traps (NETs) in COVID-19 pathogenesis.</p><p class="" id=d11369e585>Cardiac findings like myocardial hypertrophy and focal cardiomyocyte necrosis were found<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup> upon autopsy studies. Although cardiac muscle fibers were subjected to necrotic death, rare infiltration of lymphocytes adjacent to (but not surrounding) the necrotic cells rules out the development of virus-induced myocarditis. The abovementioned studies were successful in isolating viral genomic RNA from the liver, kidney, and brain, denoting viral spread from pulmonary to distant tissues. Analysis of renal tissue revealed damage to the nephronal tubular lumen and epithelium along with virus-like structures in podocytes and glomerular endothelial cells. A study by Varga <i>et al.</i><sup><a href="#ref-58">58</a></sup> indicated lymphocytic endotheliitis in the vasculature of organs such as the heart, lungs, liver, small intestine, and kidneys upon post-mortem analysis, thus underscoring the importance of vascular physiology in maintaining hemostasis and preventing multi-organ dysfunction.</p><p class="" id=d11369e601>The pulmonary pathology observed in the course of COVID-19 progression has been generally attributed to direct effect due to viral propagation and the exaggerated wave of inflammatory response imposed to combat viral infection (<a href="#f1">Figure 1b</a>). Infection of pneumocytes by SARS-CoV-2 has been reported to result in upregulation of hACE2 receptors, thus further enhancing viral entry into the cell and promoting viral propagation<sup><a href="#ref-59">59</a></sup>, which ultimately leads to pneumocyte death and pulmonary pathology. This virus-induced ACE2 upregulation has been observed to be mediated in an IFN-dependent fashion. On the other hand, one report<sup><a href="#ref-24">24</a></sup> indicates a role for an exaggerated inflammatory response as exemplified by the upregulation of serum proinflammatory markers such as IL-6, IP-10, MCP-1, and MIP-1α upon severity of COVID-19, thus indicating the induction of a severe cascade of proinflammatory reactions and its effect upon disease pathogenesis. In addition, serum level D-dimer was observed to be enhanced in critical COVID-19 patients, suggesting induction of coagulopathy. Besides the insight provided by autopsy studies regarding the immune landscape of the pulmonary system in the context of COVID-19, work by Liao <i>et al.</i><sup><a href="#ref-60">60</a></sup> demonstrated the role of FCN1<sup>+</sup> macrophages in aggravating the severity of pulmonary pathology upon infection by SARS-CoV-2. FCN1<sup>+</sup> macrophages are characterized by high levels of chemokine production implicated in the cytokine storm. Indeed, an increased population of FCN1<sup>+</sup> macrophages was found in the BAL fluid from critically ill COVID-19 cases when compared to that from mild cases, thus implicating its role in resulting overt inflammatory sequence of events followed by poor prognosis. Pneumocyte pyroptosis upon infection by SARS-CoV-2 results in the secretion of a plethora of immune-activating molecules. These molecular species typically exhibit immunostimulatory effects upon the innate immune cells of the lungs, including alveolar macrophages, thus eliciting a wave of inflammatory reactions. The cytokines and chemokines secreted by these innate immune cells further help in the recruitment of adaptive immune cells like CD8<sup>+</sup> T-cells, CD4<sup>+</sup> T-cells, and B-cells<sup><a href="#ref-61">61</a></sup>. Extravasation of these adaptive immune cells with NK cells upon the call emanating from inflamed pulmonary interstitium leads to activation of these newly secreting cells, which further respond by secreting proinflammatory mediators such as IFN-γ. These chemicals help in further activation of already activated innate immune cells, hence creating a vicious inflammatory reaction. Indeed, reduced type I and III IFN abundance in blood transcriptome accompanied by enhanced cytokine (including IL-6) and chemokine levels are speculated to contribute to COVID-19 pathogenesis<sup><a href="#ref-62">62</a></sup>. The lymphopenia in serum accompanied by SARS-CoV-2 infection is hypothesized to result from this altered distribution of lymphocytes from serum to lung parenchyma, as suggested by Cao <i>et al.</i><sup><a href="#ref-63">63</a></sup>. However, some results<sup><a href="#ref-64">64</a></sup> point towards the role for direction infection-induced exhaustion of CD8<sup>+</sup> T-cells, thus resulting in the diminution of blood lymphocyte count. SARS-CoV-2-induced lymphopenia along with elevated neutrophil count in blood comprise the increased neutrophil-to-lymphocyte ratio, which has been implicated as an independent risk factor negatively regulating disease outcome<sup><a href="#ref-65">65</a></sup>. This elevated neutrophil-to-lymphocyte ratio has been observed to be associated with NET formation in serum<sup><a href="#ref-66">66</a></sup>. Exposure of <i>in vitro</i> neutrophils from healthy control subjects to COVID-19-derived patient serum induced NET formation, thus suggesting a role for an as-yet-unknown factor promoting the latter. Moreover, the propensity of NET formation was indeed found to be positively correlated with the severity of disease. SARS-CoV-2-induced cytokine storm has also been stated to have implications in the management of patients suffering from systemic lupus erythematous (SLE)<sup><a href="#ref-67">67</a></sup>. Owing to higher susceptibility of ROS-induced (for example, in the instance of viral infection) DNA hypomethylation, SLE patients are more prone to ACE2, proinflammatory cytokines, and their transcription factors like NF-κB overexpression, ultimately culminating in enhanced viral propagation and cytokine storm development. Thus, besides having implications in disease progression and outcome, COVID-19-associated cytokine storm warrants strict management of lupus erythematosus in SLE patients in order to avoid overt outcomes in the face of SARS-CoV-2 infection.</p><p class="" id=d11369e675>Although SARS-CoV-2 infection has been associated with diffuse bilateral alveolar damage, autopsy reports point towards frequent incidences of capillary thrombus and intravascular clotting in both lungs and extra-pulmonary sites. Overt immune response against SARS-CoV-2 has been mentioned to contribute to this diffuse coagulopathy<sup><a href="#ref-63">63</a>,<a href="#ref-68">68</a></sup>. The cytokine IL-6 has been implicated in triggering the coagulation cascade activity concomitantly with reduced fibrinolysis. However, owing to high expression of ACE2 receptor in blood vessel endothelial cells, direct cell death as a result of endothelial cell infection by SARS-CoV-2 may predispose the coagulation system to overt activation, hence leading to intravascular clotting disorder. Ventilation-perfusion mismatch resulting in hypoxia may also activate the clotting cascade in the pulmonary vasculature in an inflammation-dependent manner. Further investigations aimed at elucidating the mechanistic basis for this exaggerated immune system activation upon infection by SARS-CoV-2 might provide sufficient insights into the development of therapeutic strategies against COVID-19.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11369e689>Therapy and vaccine development: where are we?</h2><p class="" id=d11369e692>Although no preventive or therapeutic strategies against 2019-nCoV exist to date, researchers across the globe are continuing to search for one (<a href="#T1">Table 1</a>). In the confrontation of a global health emergency, the repurposing of drugs has become a very popular choice for researchers in the quest for therapeutics.</p><p class="" id=d11369e698>A report by Zhou <i>et al.</i><sup><a href="#ref-80">80</a></sup> presented an integrative antiviral drug repurposing methodology by employing a system pharmacology-based network medicine platform, which helped to identify the possible therapeutic efficacy of 16 candidate repurposable drugs and three potential drug combinations. Drugs like toremifene, equilin, irbesartan, sirolimus, mercaptopurine, melatonin, and eplerenone, on the basis of their interactions with host proteins and the proximity measures of those target proteins with coronavirus-induced proteome changes, are possible future therapeutics in combating 2019-nCoV infection following further preclinical and clinical studies.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Summary of the major therapeutic strategies under clinical trial, their respective preliminary outcomes, and the putative mechanisms behind their actions.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d11369e718 class=n-a></a><thead><a name=d11369e720 class=n-a></a><tr><a name=d11369e722 class=n-a></a><th align=center colspan=1 rowspan=1 valign=middle><a name=d11369e724 class=n-a></a>Therapy: drug/drug<br class=br>combinations &amp; others</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d11369e729 class=n-a></a>Putative mechanism of action</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d11369e732 class=n-a></a>Recent developments in clinical<br class=br>trials</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d11369e737 class=n-a></a>References(s)</th></tr></thead><tbody><a name=d11369e742 class=n-a></a><tr><a name=d11369e744 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e746 class=n-a></a>Remdesivir</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e749 class=n-a></a>Possibly by inducing mutagenesis<br class=br>and/or premature viral replication<br class=br>termination</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e756 class=n-a></a>A numerical reduction in time to<br class=br>clinical improvement,albeit not<br class=br>statistically significant</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e763 class=n-a></a><a href="#ref-69">69</a></td></tr><tr><a name=d11369e768 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e770 class=n-a></a>Hydroxychloroquine</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e773 class=n-a></a>Interfere with viral entry as well as<br class=br>post-entry steps</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e778 class=n-a></a>Open-label randomized controlled<br class=br>trial indicated no improvement of<br class=br>COVID-19 patients</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e785 class=n-a></a><a href="#ref-70">70</a></td></tr><tr><a name=d11369e790 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e792 class=n-a></a>Ritonavir-Iopinavir</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e795 class=n-a></a>HIV-protease inhibitor</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e798 class=n-a></a>No sifnificant reduction in mortality<br class=br>upon drug administration with<br class=br>respect control</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e805 class=n-a></a><a href="#ref-71">71</a></td></tr><tr><a name=d11369e810 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e812 class=n-a></a>Favipiravir</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e815 class=n-a></a>Upon incorporation into viral RNA<br class=br>genome, favipiravir helps inhibit<br class=br>RNA-dependent RNA polymerase</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e822 class=n-a></a>Significant improvement in chest<br class=br>CT findings and reduction in virus<br class=br>clearance time</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e829 class=n-a></a><a href="#ref-72">72</a></td></tr><tr><a name=d11369e834 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e836 class=n-a></a>Tocilizumab</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e839 class=n-a></a>Monoclonal antibody directed<br class=br>against IL-6, thus hypothesized to<br class=br>ameliorate the intensity of cytokine<br class=br>storm</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e848 class=n-a></a>Drastic improvement in chest CT<br class=br>findings and reduction in oxygen<br class=br>support and serum proinflammatory<br class=br>markers</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e857 class=n-a></a><a href="#ref-73">73</a>,<a href="#ref-74">74</a></td></tr><tr><a name=d11369e866 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e868 class=n-a></a>Anakinra</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e871 class=n-a></a>Blocking IL-1α and IL-1β receptor,<br class=br>thus stated to reduce severity of<br class=br>cytokine storm</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e878 class=n-a></a>Prominent improvement in respiratory<br class=br>functions and decline in mortality</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e883 class=n-a></a><a href="#ref-75">75</a></td></tr><tr><a name=d11369e888 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e890 class=n-a></a>Interferon beta-1β,<br class=br>Ritonavir-lopinavir, ribavirn</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e895 class=n-a></a>Intereferon beta-1β: by inductiog<br class=br>antiviral immunity<br class=br> <br class=br>Ritonavir-Iopinavir: HIV-protease<br class=br>inhibitor Ribavirin: guanosine<br class=br>analog hypothesized to inhibit viral<br class=br>replication by incorporating itself into<br class=br>viral genome and thus introducing<br class=br>mutations</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e915 class=n-a></a>Significantly rapid virus clearance<br class=br>from nasopharyngeal and<br class=br>oropharyngeal swab and rapid<br class=br>improvement in clinical symptoms</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e924 class=n-a></a><a href="#ref-76">76</a></td></tr><tr><a name=d11369e929 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e931 class=n-a></a>Baricitinib</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e934 class=n-a></a>Inhibitor of Janus kinase activation,<br class=br>thus reducing severity of cytokine<br class=br>storm</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e941 class=n-a></a>Prominent improvement in respiratory<br class=br>and clinical functions and significant<br class=br>reduction in time to recovery</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e948 class=n-a></a><a href="#ref-77">77</a></td></tr><tr><a name=d11369e953 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e955 class=n-a></a>Convalescent plasma (CP)<br class=br>therapy</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e960 class=n-a></a>Neutralization of SARS-CoV-2 viral<br class=br>particles, thus imparting protection</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e965 class=n-a></a>Improvement in chest radiological<br class=br>findings, clearance of vira RNA,<br class=br>restoration of normal CRP level, and<br class=br>correction of lymphopenia</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e974 class=n-a></a><a href="#ref-78">78</a></td></tr><tr><a name=d11369e979 class=n-a></a><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e981 class=n-a></a>Adn5-nCoV vaccine<br class=br>candidate</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e986 class=n-a></a>Vaccine comprises adenovirus<br class=br>type-5 vector expressing S protein,<br class=br>thus conferring both B- and T-cell<br class=br>immunity</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e995 class=n-a></a>Significant B- and T-cell immunity<br class=br>was observed to be developed upon<br class=br>administration of vaccine</td><td align=center colspan=1 rowspan=1 valign=middle><a name=d11369e1002 class=n-a></a><a href="#ref-79">79</a></td></tr></tbody></table></div><p class="" id=d11369e1010>Data published by Wang <i>et al.</i><sup><a href="#ref-81">81</a></sup> reported the <i>in vitro</i> efficacy of remdesivir and chloroquine in abrogating infection by 2019-nCoV. Remdesivir is a nucleoside analog that has been reported to affect viral propagation either by inducing mutagenesis or by resulting in premature replication termination<sup><a href="#ref-82">82</a></sup>. Chloroquine, on the other hand, is an anti-malarial drug that has been shown to possess broad-spectrum anti-viral activity<sup><a href="#ref-83">83</a></sup>. Chloroquine has been demonstrated to ameliorate viral entry by inhibiting viral envelope fusion with the endosomal membrane as well by altering the glycosylation status of SARS-CoV receptors<sup><a href="#ref-84">84</a></sup>. A report by Wang <i>et al.</i><sup><a href="#ref-81">81</a></sup> illustrated the effects of remdesivir at a post-entry step, whereas chloroquine was observed to inhibit viral propagation at both entry and post-entry stages. A similar study by Liu <i>et al.</i><sup><a href="#ref-85">85</a></sup> assessed the therapeutic efficiency of hydroxychloroquine (HQ) against SARS-CoV-2 infection <i>in vitro</i> in comparison to that of chloroquine owing to the fact that HQ is 40% less toxic than chloroquine in animals. HQ was found to inhibit viral propagation at both entry and post-entry steps, albeit with a moderately lower potency than chloroquine. In addition to its antiviral activity, the authors suggest that the anti-inflammatory properties of HQ might also lead to reduced magnitude of inflammatory reaction in the face of cytokine storm elicited by 2019-nCoV, thus reducing inflammation-induced pulmonary damage. The results of an open-label non-randomized clinical trial published by Guatret <i>et al.</i><sup><a href="#ref-86">86</a></sup> indicate improved outcomes in 2019-CoV patients upon administration of HQ with or without azithromycin. In a group of 26 patients, 70% of patients receiving HQ treatment were found to be negative for viral RNA at day 6 post-inclusion. Within the same period of time, 100% of patients receiving HQ along with azithromycin were observed to be negative for viral RNA on nasopharyngeal swab. Contrary to the beneficial effects of HQ shown by the abovementioned trial, a recent multi-center, open-label randomized controlled trial involving 150 participants indicated no improvement in virus clearance upon administration of HQ at a dose of 1,200 mg daily for 3 days followed by a maintenance dose of 800 mg for 2–3 weeks for patients with mild-to-moderate/severe disease, respectively<sup><a href="#ref-70">70</a></sup>. In addition, a significantly greater proportion of patients exhibited adverse effects such as diarrhea upon treatment with HQ when compared to standard care, thus raising questions about the real efficacy and safety profile in COVID-19 patients. Similarly, in contrast to the promising outcome of remdesivir action <i>in vitro</i> against SARS-CoV-2 infection, a recently published report<sup><a href="#ref-69">69</a></sup> indicated no statistically significant clinical benefits of remdesivir administration in the context of COVID-19. However, a numerical reduction in time to clinical improvement was noted in patients treated early with the drug. Future trials involving a larger number of participants are thus warranted to confirm this finding.</p><p class="" id=d11369e1069>A clinical trial to assess the therapeutic activity of ritonavir-lopinavir combination conducted by Cao <i>et al.</i><sup><a href="#ref-71">71</a></sup> did not show any beneficial effect of therapy in the setting of 2019-nCoV infection. Ritonavir and lopinavir are HIV protease inhibitors which have already been demonstrated to be effective in treating SARS-CoV infection in patients<sup><a href="#ref-87">87</a></sup>. The mortality rate was found to be similar in the drug-treated and control group of patients (receiving standard care) at 28 days post-onset of therapy. However, a post-hoc subgroup analysis revealed reduced mortality of patients receiving ritonavir-lopinavir within 12 days of symptom onset when compared to that of patients receiving standard care within the same time window.</p><p class="" id=d11369e1082>Favipiravir is a purine nucleoside analog which, upon entry into the cell, undergoes ribosylation and phosphorylation followed by incorporation into viral RNA genome during virus replication<sup><a href="#ref-88">88</a></sup>. Upon incorporation into the viral genome, it helps inhibit viral RNA-dependent RNA polymerase (RdRp) enzyme, thus culminating in abrogated viral replication. Owing to the fact that SARS-CoV-2 is an RNA virus whose replication is dependent upon RdRp, favipiravir was subjected to investigation to assess its therapeutic potential<sup><a href="#ref-72">72</a></sup>. Treatment with favipiravir was associated with shorter virus clearance time and significant improvement in chest CT findings, thus indicating its possible use as a treatment strategy for COVID-19. However, a future multi-center controlled randomized trial is necessary before commenting on the efficacy of favipiravir against SARS-CoV-2 infection.</p><p class="" id=d11369e1093>As mentioned previously, the pathogenesis of COVID-19 is believed to heavily depend upon the ensuing cytokine storm against virus propagation. IL-6, being implicated in the SARS-CoV-2-induced cytokine storm, has been targeted using the monoclonal antibody tocilizumab. A report by Xu <i>et al.</i><sup><a href="#ref-73">73</a></sup> demonstrated the outcome of tocilizumab treatment via an intravenous route upon COVID-19 outcome in critically ill patients. Administration of tocilizumab resulted in a reduction in blood proinflammatory markers such as CRP, improved chest CT findings, restoration of lymphopenia, and improved oxygen support. Subcutaneous administration of tocilizumab<sup><a href="#ref-74">74</a></sup> was also observed to reduce oxygen support requirements in patients with multiple co-morbid conditions. A further clinical trial (NCT04317092) is underway which will provide clear insight into this drug’s therapeutic efficacy in treating COVID-19. Besides using IL-6 as a therapeutic target for COVID-19, an inhibitor against IL-1 has also been subjected to investigation for its effect upon disease progression<sup><a href="#ref-75">75</a></sup>. Anakinra is an IL-1α and IL-β receptor blocker which has been observed to abrogate IL-1 signaling and thus been employed as a treatment for multiple autoimmune disorders<sup><a href="#ref-89">89</a></sup>. Upon treatment with anakinra for 21 days, significant restoration of serum CRP level was noted in comparison to the control group. Improvement in respiratory function was also associated with significant reduction in mortality with respect to the control group. A similar strategy aiming to inhibit the effects of proinflammatory mediators by the use of the anti-inflammatory drug baricitinib has been shown to successfully control disease progression<sup><a href="#ref-77">77</a></sup>. Baricitinib, reported to inhibit Janus kinase activation, is licensed for treating autoimmune conditions such as rheumatoid arthritis<sup><a href="#ref-90">90</a></sup>. Treatment of a small group of COVID-19 patients using baricitinib resulted in significant improvement of clinical and respiratory functions along with drastic reduction in time to recovery. Promising results in COVID-19 clinical trials aiming to inhibit proinflammatory mediators thus underscore the role of cytokine storm in disease severity and outcome. A study by Hung <i>et al.</i><sup><a href="#ref-76">76</a></sup> provided the outcome of COVID-19 patients upon use of a drug combination consisting of IFN beta-Ib, lopinavir-ritonavir, and ribavirin. Use of this combination led to rapid clearance of viral RNA from nasopharyngeal and oropharyngeal samples, which was also accompanied by rapid alleviation of symptoms in comparison with the control group.</p><p class="" id=d11369e1129>An unpublished study<sup><a href="#ref-91">91</a></sup> aiming to evaluate the neutralizing potential of antibodies against SARS-CoV-2 in a recovered COVID-19 cohort points to a very dynamic range of neutralizing activity, as exhibited by an undetectable level of the virus in some patients. Albeit this finding raises concerns regarding the potential of antibody response to protect against reinfection by SARS-CoV-2, a report by Chandrashekar <i>et al</i>. established a macaque model for SARS-CoV-2 infection wherein re-challenge with SARS-CoV-2 failed to induce reinfection in a humoral as well as cell-mediated immunity-dependent fashion. In agreement with the study mentioned above stating the role of SARS-CoV-2-induced humoral immunity in preventing reinfection, a study by Duan <i>et al</i>.<sup><a href="#ref-78">78</a></sup> demonstrated the effectiveness of convalescent plasma from recovered COVID-19 patients in treating individuals suffering from severe COVID-19. Parameters like serum CRP level and lymphocyte count were found to be restored to normal values. Significant improvement was observed in radiological chest findings accompanied by clearance of viral RNA post-plasma therapy. This study thus highlights the low risk of treatment and potential of convalescent plasma therapy in neutralizing viral particles and thus conferring protection against severe COVID-19 progression and outcome. Another study estimating the efficacy of convalescent serum as a treatment in a larger cohort is currently underway (NCT04264858), which upon completion will help direct therapeutic strategies in the face of this pandemic.</p><p class="" id=d11369e1146>Researchers across the world are racing against time to develop a vaccine against 2019-nCoV. However, because of the lack of any existing vaccine against coronaviruses, building the processes and capacities will demand painstaking labor and time. A joint effort by Moderna and the vaccine research center at the National Institutes of Health has led to the design of an mRNA-based vaccine (mRNA for S gene encapsulated in lipid nanoparticles<sup><a href="#ref-92">92</a></sup>), which is currently undergoing a recently started phase 1 clinical trial (NCT04283461). Curevac is also working on an mRNA-based vaccine which has been reported very recently to exhibit promising results in preclinical analysis, as denoted by the development of a significant titer of neutralizing SARS-CoV-2-antibodies<sup><a href="#ref-93">93</a></sup>. A very recent study by Zhu <i>et al</i>.<sup><a href="#ref-79">79</a></sup> assessed the safety profile and efficacy of an adenoviral vector-based RNA vaccine possessing the gene for S protein. This vaccine candidate was found to be well tolerated and capable of eliciting both B- and T-cell immunity 28 and 14 days after administration, respectively, thus warranting further large-scale study before it can be utilized for prophylaxis against SARS-CoV-2 infection. Realistically, considering the time required for efficacy and safety assessment, the establishment of mass production processes, large-scale vaccine production, and distribution in both high- and low-income countries followed by vaccination, which requires trained individuals, it will be very difficult for a SARS-CoV-2 vaccine to be available before another 12–18 months<sup><a href="#ref-94">94</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11369e1171>Conclusion</h2><p class="" id=d11369e1174>Infection by SARS-CoV-2 has been declared a global health emergency owing to the rapid spread of the virus irrespective of national boundaries and the destructive impacts it has imposed upon the healthcare system as well as the economy. The development of a vaccine is a time-consuming, cumbersome, and expensive process, especially when novel vaccine platforms are being proposed for disease control. On the other hand, the repurposing/repositioning of existing drugs might provide researchers with a more realistic way to search for and use already approved drugs in this time of urgent need. Although scientists across the world are continuing their search for therapies or vaccines to fight off SARS-CoV-2 infection, a wide gap still exists in our knowledge of SARS-CoV-2 biology. Owing to the lack of any definitive proof of the virus’ origin or regarding the role of any intermediate carrier/reservoir animal species, further work aiming to elucidate the viral emergence and molecular basis of species barrier jump might help in the prevention of any future pandemics like the current one. Further understanding of disease progression warrants the development of an animal model of SARS-CoV-2 infection which might provide detailed insights into the disease’s biology and point towards the development of multiple possible therapeutic strategies.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d11369e1181 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading is-hidden"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d12082>References</h2><div class="section ref-list"><a name=d11369e1181 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d11369e1188 class=n-a></a>Hui DSC, Wong PC, Wang C: SARS: Clinical features and diagnosis. <i>Respirology.</i> 2003; <b>8 Suppl</b>(Suppl 1): S20–4. <a target=xrefwindow id=d11369e1196 href="http://www.ncbi.nlm.nih.gov/pubmed/15018129">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1199 href="https://doi.org/10.1046/j.1440-1843.2003.00520.x">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1202 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7169175">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d11369e1211 class=n-a></a>Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, <i> et al.</i>: Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. <i>Lancet Infect Dis.</i> 2013; <b>13</b>(9): 752–61. <a target=xrefwindow id=d11369e1222 href="http://www.ncbi.nlm.nih.gov/pubmed/23891402">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1225 href="https://doi.org/10.1016/S1473-3099(13)70204-4">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1229 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7185445">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d11369e1238 class=n-a></a>Lu R, Zhao X, Li J, <i> et al.</i>: Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. <i>Lancet.</i> 2020; <b>395</b>(10224): 565–74. <a target=xrefwindow id=d11369e1249 href="http://www.ncbi.nlm.nih.gov/pubmed/32007145">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1252 href="https://doi.org/10.1016/S0140-6736(20)30251-8">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1256 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7159086">Free Full Text </a></span><div class=note><a name=d11369e1258 class=n-a></a><p class=first id=d11369e1259><a target=xrefwindow href="https://facultyopinions.com/prime/737287248" id=d11369e1260>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d11369e1269 class=n-a></a>Chan JFW, Yuan S, Kok KH, <i> et al.</i>: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. <i>Lancet.</i> 2020; <b>395</b>(10223): 514–23. <a target=xrefwindow id=d11369e1280 href="http://www.ncbi.nlm.nih.gov/pubmed/31986261">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1283 href="https://doi.org/10.1016/S0140-6736(20)30154-9">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1287 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7159286">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d11369e1296 class=n-a></a>Zhang T, Wu Q, Zhang Z: Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. <i>Curr Biol.</i> 2020; <b>30</b>(7): 1346–1351.e2. <a target=xrefwindow id=d11369e1304 href="http://www.ncbi.nlm.nih.gov/pubmed/32197085">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1307 href="https://doi.org/10.1016/j.cub.2020.03.022">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1310 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7156161">Free Full Text </a></span><div class=note><a name=d11369e1312 class=n-a></a><p class=first id=d11369e1313><a target=xrefwindow href="https://facultyopinions.com/prime/737584512" id=d11369e1314>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d11369e1324 class=n-a></a>Liu P, Jiang JZ, Wan XF, <i> et al.</i>: Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? <i>PLoS Pathog.</i> 2020; <b>16</b>(5): e1008421. <a target=xrefwindow id=d11369e1335 href="http://www.ncbi.nlm.nih.gov/pubmed/32407364">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1338 href="https://doi.org/10.1371/journal.ppat.1008421">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7224457">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d11369e1351 class=n-a></a>Andersen KG, Rambaut A, Lipkin WI, <i> et al.</i>: The proximal origin of SARS-CoV-2. <i>Nat Med.</i> 2020; <b>26</b>(4): 450–2. <a target=xrefwindow id=d11369e1362 href="http://www.ncbi.nlm.nih.gov/pubmed/32284615">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1365 href="https://doi.org/10.1038/s41591-020-0820-9">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7095063">Free Full Text </a></span><div class=note><a name=d11369e1371 class=n-a></a><p class=first id=d11369e1372><a target=xrefwindow href="https://facultyopinions.com/prime/737560926" id=d11369e1373>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d11369e1382 class=n-a></a>Li Q, Guan X, Wu P, <i> et al.</i>: Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. <i>N Engl J Med.</i> 2020; <b>382</b>(13): 1199–207. <a target=xrefwindow id=d11369e1393 href="http://www.ncbi.nlm.nih.gov/pubmed/31995857">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1396 href="https://doi.org/10.1056/NEJMoa2001316">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1400 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7121484">Free Full Text </a></span><div class=note><a name=d11369e1402 class=n-a></a><p class=first id=d11369e1403><a target=xrefwindow href="https://facultyopinions.com/prime/737281536" id=d11369e1404>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d11369e1413 class=n-a></a>Chapman HA, Wei Y, Montas G, <i> et al.</i>: Reversal of TGF<i>β</i>1-Driven Profibrotic State in Patients with Pulmonary Fibrosis. <i>N Engl J Med.</i> 2020; <b>382</b>(11): 1068–70. <a target=xrefwindow id=d11369e1427 href="http://www.ncbi.nlm.nih.gov/pubmed/32160670">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1431 href="https://doi.org/10.1056/NEJMc1915189">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1434 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7297220">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d11369e1443 class=n-a></a>Holshue ML, DeBolt C, Lindquist S, <i> et al.</i>: First Case of 2019 Novel Coronavirus in the United States. <i>N Engl J Med.</i> 2020; <b>382</b>(10): 929–36. <a target=xrefwindow id=d11369e1454 href="http://www.ncbi.nlm.nih.gov/pubmed/32004427">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1457 href="https://doi.org/10.1056/NEJMoa2001191">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1461 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7092802">Free Full Text </a></span><div class=note><a name=d11369e1463 class=n-a></a><p class=first id=d11369e1464><a target=xrefwindow href="https://facultyopinions.com/prime/737289584" id=d11369e1465>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d11369e1474 class=n-a></a>Sun K, Chen J, Viboud C: Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: A population-level observational study. <i>Lancet Digit Health.</i> 2020; <b>2</b>(4): e201–e208. <a target=xrefwindow id=d11369e1482 href="http://www.ncbi.nlm.nih.gov/pubmed/32309796">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1485 href="https://doi.org/10.1016/S2589-7500(20)30026-1">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1488 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7158945">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d11369e1498 class=n-a></a>Wu JT, Leung K, Bushman M, <i> et al.</i>: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. <i>Nat Med.</i> 2020; <b>26</b>(4): 506–10. <a target=xrefwindow id=d11369e1509 href="http://www.ncbi.nlm.nih.gov/pubmed/32284616">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1512 href="https://doi.org/10.1038/s41591-020-0822-7">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1516 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7094929">Free Full Text </a></span><div class=note><a name=d11369e1518 class=n-a></a><p class=first id=d11369e1519><a target=xrefwindow href="https://facultyopinions.com/prime/737582556" id=d11369e1520>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d11369e1529 class=n-a></a>Delamater PL, Street EJ, Leslie TF, <i> et al.</i>: Complexity of the Basic Reproduction Number (R<sub>0</sub>). <i>Emerging Infect Dis.</i> 2019; <b>25</b>(1): 1–4. <a target=xrefwindow id=d11369e1543 href="http://www.ncbi.nlm.nih.gov/pubmed/30560777">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1547 href="https://doi.org/10.3201/eid2501.171901">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1550 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6302597">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d11369e1559 class=n-a></a>Song Z, Xu Y, Bao L, <i> et al.</i>: From SARS to MERS, Thrusting Coronaviruses into the Spotlight. <i>Viruses.</i> 2019; <b>11</b>(1): 59. <a target=xrefwindow id=d11369e1570 href="http://www.ncbi.nlm.nih.gov/pubmed/30646565">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1573 href="https://doi.org/10.3390/v11010059">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6357155">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d11369e1586 class=n-a></a>Cui J, Li F, Shi ZL: Origin and evolution of pathogenic coronaviruses. <i>Nat Rev Microbiol.</i> 2019; <b>17</b>(3): 181–92. <a target=xrefwindow id=d11369e1594 href="http://www.ncbi.nlm.nih.gov/pubmed/30531947">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1597 href="https://doi.org/10.1038/s41579-018-0118-9">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1600 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7097006">Free Full Text </a></span><div class=note><a name=d11369e1602 class=n-a></a><p class=first id=d11369e1603><a target=xrefwindow href="https://facultyopinions.com/prime/734602640" id=d11369e1604>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d11369e1613 class=n-a></a>Wu A, Peng Y, Huang B, <i> et al.</i>: Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. <i>Cell Host Microbe.</i> 2020; <b>27</b>(3): 325–8. <a target=xrefwindow id=d11369e1624 href="http://www.ncbi.nlm.nih.gov/pubmed/32035028">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1627 href="https://doi.org/10.1016/j.chom.2020.02.001">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1631 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7154514">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d11369e1640 class=n-a></a>Belouzard S, Chu VC, Whittaker GR: Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. <i>Proc Natl Acad Sci U S A.</i> 2009; <b>106</b>(14): 5871–6. <a target=xrefwindow id=d11369e1648 href="http://www.ncbi.nlm.nih.gov/pubmed/19321428">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1651 href="https://doi.org/10.1073/pnas.0809524106">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1654 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2660061">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d11369e1664 class=n-a></a>Tortorici MA, Veesler D: Structural insights into coronavirus entry. <i>Adv Virus Res.</i> 2019; <b>105</b>: 93–116. <a target=xrefwindow id=d11369e1672 href="http://www.ncbi.nlm.nih.gov/pubmed/31522710">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1675 href="https://doi.org/10.1016/bs.aivir.2019.08.002">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1678 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7112261">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d11369e1687 class=n-a></a>Millet JK, Whittaker GR: Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(42): 15214–9. <a target=xrefwindow id=d11369e1695 href="http://www.ncbi.nlm.nih.gov/pubmed/25288733">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1698 href="https://doi.org/10.1073/pnas.1407087111">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1701 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4210292">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d11369e1710 class=n-a></a>Klenk HD, Garten W: Host cell proteases controlling virus pathogenicity. <i>Trends Microbiol.</i> 1994; <b>2</b>(2): 39–43. <a target=xrefwindow id=d11369e1718 href="http://www.ncbi.nlm.nih.gov/pubmed/8162439">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1721 href="https://doi.org/10.1016/0966-842x(94)90123-6">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d11369e1730 class=n-a></a>Bagdonaite I, Wandall HH: Global aspects of viral glycosylation. <i>Glycobiology.</i> 2018; <b>28</b>(7): 443–67. <a target=xrefwindow id=d11369e1738 href="http://www.ncbi.nlm.nih.gov/pubmed/29579213">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1741 href="https://doi.org/10.1093/glycob/cwy021">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1744 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7108637">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d11369e1753 class=n-a></a>Zhou P, Yang XL, Wang XG, <i> et al.</i>: A pneumonia outbreak associated with a new coronavirus of probable bat origin. <i>Nature.</i> 2020; <b>579</b>(7798): 270–3. <a target=xrefwindow id=d11369e1764 href="http://www.ncbi.nlm.nih.gov/pubmed/32015507">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1767 href="https://doi.org/10.1038/s41586-020-2012-7">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1771 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7095418">Free Full Text </a></span><div class=note><a name=d11369e1773 class=n-a></a><p class=first id=d11369e1774><a target=xrefwindow href="https://facultyopinions.com/prime/737304963" id=d11369e1775>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d11369e1784 class=n-a></a>Hoffmann M, Kleine-Weber H, Schroeder S, <i> et al.</i>: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. <i>Cell.</i> 2020; <b>181</b>(2): 271–280.e8. <a target=xrefwindow id=d11369e1795 href="http://www.ncbi.nlm.nih.gov/pubmed/32142651">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1798 href="https://doi.org/10.1016/j.cell.2020.02.052">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1802 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7102627">Free Full Text </a></span><div class=note><a name=d11369e1804 class=n-a></a><p class=first id=d11369e1805><a target=xrefwindow href="https://facultyopinions.com/prime/737494462" id=d11369e1806>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d11369e1816 class=n-a></a>Huang C, Wang Y, Li X, <i> et al.</i>: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. <i>Lancet.</i> 2020; <b>395</b>(10223): 497–506. <a target=xrefwindow id=d11369e1827 href="http://www.ncbi.nlm.nih.gov/pubmed/31986264">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1830 href="https://doi.org/10.1016/S0140-6736(20)30183-5">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1834 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7159299">Free Full Text </a></span><div class=note><a name=d11369e1836 class=n-a></a><p class=first id=d11369e1837><a target=xrefwindow href="https://facultyopinions.com/prime/737258313" id=d11369e1838>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d11369e1847 class=n-a></a>Antonio GE, Wong KT, Hui DSC, <i> et al.</i>: Imaging of severe acute respiratory syndrome in Hong Kong. <i>AJR Am J Roentgenol.</i> 2003; <b>181</b>(1): 11–7. <a target=xrefwindow id=d11369e1858 href="http://www.ncbi.nlm.nih.gov/pubmed/12818822">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1861 href="https://doi.org/10.2214/ajr.181.1.1810011">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d11369e1870 class=n-a></a>Wong CK, Lam CW, Wu AK, <i> et al.</i>: Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. <i>Clin Exp Immunol.</i> 2004; <b>136</b>(1): 95–103. <a target=xrefwindow id=d11369e1881 href="http://www.ncbi.nlm.nih.gov/pubmed/15030519">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1884 href="https://doi.org/10.1111/j.1365-2249.2004.02415.x">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1888 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1808997">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d11369e1897 class=n-a></a>Chen N, Zhou M, Dong X, <i> et al.</i>: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. <i>Lancet.</i> 2020; <b>395</b>(10223): 507–13. <a target=xrefwindow id=d11369e1908 href="http://www.ncbi.nlm.nih.gov/pubmed/32007143">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1911 href="https://doi.org/10.1016/S0140-6736(20)30211-7">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1915 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7135076">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d11369e1924 class=n-a></a>Bangash MN, Patel J, Parekh D: COVID-19 and the liver: Little cause for concern. <i>Lancet Gastroenterol Hepatol.</i> 2020; <b>5</b>(6): 529–30. <a target=xrefwindow id=d11369e1932 href="http://www.ncbi.nlm.nih.gov/pubmed/32203680">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1935 href="https://doi.org/10.1016/S2468-1253(20)30084-4">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1938 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7270582">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d11369e1947 class=n-a></a>Shi H, Han X, Jiang N, <i> et al.</i>: Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. <i>Lancet Infect Dis.</i> 2020; <b>20</b>(4): 425–34. <a target=xrefwindow id=d11369e1958 href="http://www.ncbi.nlm.nih.gov/pubmed/32105637">PubMed Abstract </a> | <a target=xrefwindow id=d11369e1961 href="https://doi.org/10.1016/S1473-3099(20)30086-4">Publisher Full Text </a> | <a target=xrefwindow id=d11369e1965 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7159053">Free Full Text </a></span><div class=note><a name=d11369e1967 class=n-a></a><p class=first id=d11369e1968><a target=xrefwindow href="https://facultyopinions.com/prime/737450266" id=d11369e1969>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d11369e1979 class=n-a></a>Imaging M: Original Report. <i>Rev Lit Arts Am.</i> 2005; 200–4. </span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d11369e1991 class=n-a></a>Wong KT, Antonio GE, Hui DSC, <i> et al.</i>: Thin-section CT of severe acute respiratory syndrome: Evaluation of 73 patients exposed to or with the disease. <i>Radiology.</i> 2003; <b>228</b>(2): 395–400. <a target=xrefwindow id=d11369e2002 href="http://www.ncbi.nlm.nih.gov/pubmed/12738877">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2005 href="https://doi.org/10.1148/radiol.2283030541">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d11369e2014 class=n-a></a>Das KM, Lee EY, Enani MA, <i> et al.</i>: CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. <i>AJR Am J Roentgenol.</i> 2015; <b>204</b>(4): 736–42. <a target=xrefwindow id=d11369e2025 href="http://www.ncbi.nlm.nih.gov/pubmed/25615627">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2028 href="https://doi.org/10.2214/AJR.14.13671">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d11369e2037 class=n-a></a>Ajlan AM, Ahyad RA, Jamjoom LG, <i> et al.</i>: Middle East respiratory syndrome coronavirus (MERS-CoV) infection: Chest CT findings. <i>AJR Am J Roentgenol.</i> 2014; <b>203</b>(4): 782–7. <a target=xrefwindow id=d11369e2048 href="http://www.ncbi.nlm.nih.gov/pubmed/24918624">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2051 href="https://doi.org/10.2214/AJR.14.13021">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d11369e2060 class=n-a></a>Inciardi RM, Lupi L, Zaccone G, <i> et al.</i>: Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). <i>JAMA Cardiol.</i> 2020. <a target=xrefwindow id=d11369e2068 href="http://www.ncbi.nlm.nih.gov/pubmed/32219357">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2071 href="https://doi.org/10.1001/jamacardio.2020.1096">Publisher Full Text </a></span><div class=note><a name=d11369e2073 class=n-a></a><p class=first id=d11369e2074><a target=xrefwindow href="https://facultyopinions.com/prime/737633169" id=d11369e2075>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d11369e2084 class=n-a></a>Van den Berghe G, Bouillon R, Mesotten D: Glucose control in critically ill patients. <i>N Engl J Med.</i> 2009; <b>361</b>(1): 89; author reply 91–2. <a target=xrefwindow id=d11369e2092 href="http://www.ncbi.nlm.nih.gov/pubmed/19571290">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2095 href="https://doi.org/10.1056/NEJMc090812">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d11369e2105 class=n-a></a>Helms J, Kremer S, Merdji H, <i> et al.</i>: Neurologic Features in Severe SARS-CoV-2 Infection. <i>N Engl J Med.</i> 2020; <b>382</b>(23): 2268–2270. <a target=xrefwindow id=d11369e2116 href="http://www.ncbi.nlm.nih.gov/pubmed/32294339">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2119 href="https://doi.org/10.1056/NEJMc2008597">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2123 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7179967">Free Full Text </a></span><div class=note><a name=d11369e2125 class=n-a></a><p class=first id=d11369e2126><a target=xrefwindow href="https://facultyopinions.com/prime/737752364" id=d11369e2127>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d11369e2136 class=n-a></a>Mao L, Jin H, Wang M, <i> et al.</i>: Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. <i>JAMA Neurol.</i> 2020; <b>77</b>(6): 1–9. <a target=xrefwindow id=d11369e2147 href="http://www.ncbi.nlm.nih.gov/pubmed/32275288">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2150 href="https://doi.org/10.1001/jamaneurol.2020.1127">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2154 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7149362">Free Full Text </a></span><div class=note><a name=d11369e2156 class=n-a></a><p class=first id=d11369e2157><a target=xrefwindow href="https://facultyopinions.com/prime/737716439" id=d11369e2158>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d11369e2167 class=n-a></a>Bénézit F, Le Turnier P, Declerck C, <i> et al.</i>: Utility of hyposmia and hypogeusia for the diagnosis of COVID-19. <i>Lancet Infect Dis.</i> 2020; S1473-3099(20)30297-8. <a target=xrefwindow id=d11369e2175 href="http://www.ncbi.nlm.nih.gov/pubmed/32304632">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2178 href="https://doi.org/10.1016/S1473-3099(20)30297-8">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2181 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7159866">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d11369e2190 class=n-a></a>Moriguchi T, Harii N, Goto J, <i> et al.</i>: A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. <i>Int J Infect Dis.</i> 2020; <b>94</b>: 55–8. <a target=xrefwindow id=d11369e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/32251791">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2204 href="https://doi.org/10.1016/j.ijid.2020.03.062">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2208 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7195378">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d11369e2217 class=n-a></a>Yang X, Yu Y, Xu J, <i> et al.</i>: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. <i>Lancet Respir Med.</i> 2020; <b>8</b>(5): 475–81. <a target=xrefwindow id=d11369e2228 href="http://www.ncbi.nlm.nih.gov/pubmed/32105632">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2231 href="https://doi.org/10.1016/S2213-2600(20)30079-5">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2235 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7102538">Free Full Text </a></span><div class=note><a name=d11369e2237 class=n-a></a><p class=first id=d11369e2238><a target=xrefwindow href="https://facultyopinions.com/prime/737422643" id=d11369e2239>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d11369e2248 class=n-a></a>Bhat TA, Kalathil SG, Bogner PN, <i> et al.</i>: An Animal Model of Inhaled Vitamin E Acetate and EVALI-like Lung Injury. <i>N Engl J Med.</i> 2020; <b>382</b>(12): 1175–7. <a target=xrefwindow id=d11369e2259 href="http://www.ncbi.nlm.nih.gov/pubmed/32101656">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2262 href="https://doi.org/10.1056/NEJMc2000231">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2266 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7299285">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d11369e2276 class=n-a></a>Tsang TK, Cowling BJ, Fang VJ, <i> et al.</i>: Influenza A Virus Shedding and Infectivity in Households. <i>J Infect Dis.</i> 2015; <b>212</b>(9): 1420–8. <a target=xrefwindow id=d11369e2287 href="http://www.ncbi.nlm.nih.gov/pubmed/25883385">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2290 href="https://doi.org/10.1093/infdis/jiv225">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2294 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4601913">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d11369e2303 class=n-a></a>Peiris JSM, Chu CM, Cheng VCC, <i> et al.</i>: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. <i>Lancet.</i> 2003; <b>361</b>(9371): 1767–72. <a target=xrefwindow id=d11369e2314 href="http://www.ncbi.nlm.nih.gov/pubmed/12781535">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2317 href="https://doi.org/10.1016/s0140-6736(03)13412-5">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2321 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7112410">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d11369e2330 class=n-a></a>Zhao J, Zhao J, Legge K, <i> et al.</i>: Age-related increases in PGD<sub>2</sub> expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. <i>J Clin Invest.</i> 2011; <b>121</b>(12): 4921–30. <a target=xrefwindow id=d11369e2344 href="http://www.ncbi.nlm.nih.gov/pubmed/22105170">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2348 href="https://doi.org/10.1172/JCI59777">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2351 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3226008">Free Full Text </a></span><div class=note><a name=d11369e2353 class=n-a></a><p class=first id=d11369e2354><a target=xrefwindow href="https://facultyopinions.com/prime/13398963" id=d11369e2355>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d11369e2364 class=n-a></a>Koven S: They Call Us and We Go. <i>N Engl J Med.</i> 2020; <b>382</b>(21): 1978–9. <a target=xrefwindow id=d11369e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/32283001">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2375 href="https://doi.org/10.1056/NEJMp2009027">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d11369e2384 class=n-a></a>Molinaro GA, Lee DA, Parashar UD: Rotavirus vaccines. <i>N Engl J Med.</i> 2006; <b>354</b>(16): 1747-51; author reply 1747-51. <a target=xrefwindow id=d11369e2392 href="http://www.ncbi.nlm.nih.gov/pubmed/16625014">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2395 href="https://doi.org/10.1056/NEJMc060253">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d11369e2404 class=n-a></a>January F, Hospital T, Hospital T, <i> et al.</i>: Correspondence Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. 2020.</span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d11369e2417 class=n-a></a>Xu Y, Li X, Zhu B, <i> et al.</i>: Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. <i>Nat Med.</i> 2020; <b>26</b>(4): 502–505. <a target=xrefwindow id=d11369e2428 href="http://www.ncbi.nlm.nih.gov/pubmed/32284613">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2431 href="https://doi.org/10.1038/s41591-020-0817-4">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2435 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7095102">Free Full Text </a></span><div class=note><a name=d11369e2437 class=n-a></a><p class=first id=d11369e2438><a target=xrefwindow href="https://facultyopinions.com/prime/737540043" id=d11369e2439>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d11369e2448 class=n-a></a>Qiu H, Wu J, Hong L, <i> et al.</i>: Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. <i>Lancet Infect Dis.</i> 2020; <b>20</b>(6): 689–696. <a target=xrefwindow id=d11369e2459 href="http://www.ncbi.nlm.nih.gov/pubmed/32220650">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2462 href="https://doi.org/10.1016/S1473-3099(20)30198-5">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2466 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7158906">Free Full Text </a></span><div class=note><a name=d11369e2468 class=n-a></a><p class=first id=d11369e2469><a target=xrefwindow href="https://facultyopinions.com/prime/737619892" id=d11369e2470>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d11369e2479 class=n-a></a>Ct C: Comment Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms. 2020; <b>2</b>(20): 19–21.</span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d11369e2491 class=n-a></a>Dallan C, Romano F, Siebert J, <i> et al.</i>: Septic shock presentation in adolescents with COVID-19. <i>Lancet Child Adolesc Health.</i> 2020; <b>4</b>(7): e21–e23. <a target=xrefwindow id=d11369e2502 href="http://www.ncbi.nlm.nih.gov/pubmed/32442421">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2505 href="https://doi.org/10.1016/S2352-4642(20)30164-4">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2509 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7237371">Free Full Text </a></span><div class=note><a name=d11369e2511 class=n-a></a><p class=first id=d11369e2512><a target=xrefwindow href="https://facultyopinions.com/prime/737982867" id=d11369e2513>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d11369e2521 class=n-a></a>Cook J, Harman K, Zoica B, <i> et al.</i>: Horizontal transmission of severe acute respiratory syndrome coronavirus 2 to a premature infant: Multiple organ injury and association with markers of inflammation. <i>Lancet Child Adolesc Health.</i> 2020; <b>4</b>(7): 548–551<a target=xrefwindow id=d11369e2532 href="http://www.ncbi.nlm.nih.gov/pubmed/32442422">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2535 href="https://doi.org/10.1016/S2352-4642(20)30166-8">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2539 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7237364">Free Full Text </a></span><div class=note><a name=d11369e2541 class=n-a></a><p class=first id=d11369e2542><a target=xrefwindow href="https://facultyopinions.com/prime/738003444" id=d11369e2543>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d11369e2552 class=n-a></a>Chen H, Guo J, Wang C, <i> et al.</i>: Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. <i>The Lancet.</i> 2020; <b>395</b>(10226): 809–15. <a target=xrefwindow id=d11369e2563 href="http://www.ncbi.nlm.nih.gov/pubmed/32151335">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2566 href="https://doi.org/10.1016/S0140-6736(20)30360-3">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2570 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7159281">Free Full Text </a></span><div class=note><a name=d11369e2572 class=n-a></a><p class=first id=d11369e2573><a target=xrefwindow href="https://facultyopinions.com/prime/737378311" id=d11369e2574>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d11369e2584 class=n-a></a>Yu N, Li W, Kang Q, <i> et al.</i>: Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. <i>Lancet Infect Dis.</i> 2020; <b>20</b>(5): 559–64. <a target=xrefwindow id=d11369e2595 href="http://www.ncbi.nlm.nih.gov/pubmed/32220284">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2598 href="https://doi.org/10.1016/S1473-3099(20)30176-6">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2602 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7158904">Free Full Text </a></span><div class=note><a name=d11369e2604 class=n-a></a><p class=first id=d11369e2605><a target=xrefwindow href="https://facultyopinions.com/prime/737645282" id=d11369e2606>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d11369e2615 class=n-a></a>Wichmann D, Sperhake JP, Lütgehetmann M, <i> et al.</i>: Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. <i>Ann Intern Med.</i> 2020; M20-2003. <a target=xrefwindow id=d11369e2623 href="http://www.ncbi.nlm.nih.gov/pubmed/32374815">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2626 href="https://doi.org/10.7326/M20-2003">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2629 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7240772">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d11369e2638 class=n-a></a>Menter T, Haslbauer JD, Nienhold R, <i> et al.</i>: Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. <i>Histopathology.</i> 2020. <a target=xrefwindow id=d11369e2646 href="http://www.ncbi.nlm.nih.gov/pubmed/32364264">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2649 href="https://doi.org/10.1111/his.14134">Publisher Full Text </a></span><div class=note><a name=d11369e2651 class=n-a></a><p class=first id=d11369e2652><a target=xrefwindow href="https://facultyopinions.com/prime/737874004" id=d11369e2653>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d11369e2662 class=n-a></a>Fox SE, Akmatbekov A, Harbert JL, <i> et al.</i>: Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. <i>medRxiv.</i> 2020. <a target=xrefwindow id=d11369e2670 href="https://doi.org/10.1101/2020.04.06.20050575">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d11369e2679 class=n-a></a>Varga Z, Flammer AJ, Steiger P, <i> et al.</i>: Endothelial cell infection and endotheliitis in COVID-19. <i>Lancet.</i> 2020; <b>395</b>(10234): 1417–8. <a target=xrefwindow id=d11369e2690 href="http://www.ncbi.nlm.nih.gov/pubmed/32325026">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2693 href="https://doi.org/10.1016/S0140-6736(20)30937-5">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2697 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7172722">Free Full Text </a></span><div class=note><a name=d11369e2699 class=n-a></a><p class=first id=d11369e2700><a target=xrefwindow href="https://facultyopinions.com/prime/737790753" id=d11369e2701>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d11369e2710 class=n-a></a>Ziegler CGK, Allon SJ, Nyquist SK, <i> et al.</i>: SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. <i>Cell.</i> 2020; <b>181</b>(5): 1016–1035.e19. <a target=xrefwindow id=d11369e2721 href="http://www.ncbi.nlm.nih.gov/pubmed/32413319">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2724 href="https://doi.org/10.1016/j.cell.2020.04.035">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2728 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7252096">Free Full Text </a></span><div class=note><a name=d11369e2730 class=n-a></a><p class=first id=d11369e2731><a target=xrefwindow href="https://facultyopinions.com/prime/737831436" id=d11369e2732>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d11369e2742 class=n-a></a>Liao M, Liu Y, Yuan J, <i> et al.</i>: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. <i>Nat Med.</i> 2020; <b>26</b>(6): 842–844. <a target=xrefwindow id=d11369e2753 href="http://www.ncbi.nlm.nih.gov/pubmed/32398875">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2756 href="https://doi.org/10.1038/s41591-020-0901-9">Publisher Full Text </a></span><div class=note><a name=d11369e2758 class=n-a></a><p class=first id=d11369e2759><a target=xrefwindow href="https://facultyopinions.com/prime/737933558" id=d11369e2760>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d11369e2769 class=n-a></a>Tay MZ, Poh CM, Rénia L, <i> et al.</i>: The trinity of COVID-19: Immunity, inflammation and intervention. <i>Nat Rev Immunol.</i> 2020; <b>20</b>(6): 363–374. <a target=xrefwindow id=d11369e2780 href="http://www.ncbi.nlm.nih.gov/pubmed/32346093">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2783 href="https://doi.org/10.1038/s41577-020-0311-8">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2787 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7187672">Free Full Text </a></span><div class=note><a name=d11369e2789 class=n-a></a><p class=first id=d11369e2790><a target=xrefwindow href="https://facultyopinions.com/prime/737834640" id=d11369e2791>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d11369e2800 class=n-a></a>Blanco-Melo D, Nilsson-Payant BE, Liu WC, <i> et al.</i>: Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. <i>Cell.</i> 2020; <b>181</b>(5): 1036–1045.e9. <a target=xrefwindow id=d11369e2811 href="http://www.ncbi.nlm.nih.gov/pubmed/32416070">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2814 href="https://doi.org/10.1016/j.cell.2020.04.026">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2818 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7227586">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d11369e2827 class=n-a></a>Cao W, Li T: COVID-19: Towards understanding of pathogenesis. <i>Cell Res.</i> 2020; <b>30</b>(5): 367–9. <a target=xrefwindow id=d11369e2835 href="http://www.ncbi.nlm.nih.gov/pubmed/32346073">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2838 href="https://doi.org/10.1038/s41422-020-0327-4">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2841 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7186532">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d11369e2850 class=n-a></a>Zheng M, Gao Y, Wang G, <i> et al.</i>: Functional exhaustion of antiviral lymphocytes in COVID-19 patients. <i>Cell Mol Immunol.</i> 2020; <b>17</b>(5): 533–5. <a target=xrefwindow id=d11369e2861 href="http://www.ncbi.nlm.nih.gov/pubmed/32203188">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2864 href="https://doi.org/10.1038/s41423-020-0402-2">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2868 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7091858">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d11369e2877 class=n-a></a>Liu Y, Du X, Chen J, <i> et al.</i>: Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. <i> J Infect.</i> 2020; <b>81</b>(1): e6–e12. <a target=xrefwindow id=d11369e2888 href="http://www.ncbi.nlm.nih.gov/pubmed/32283162">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2891 href="https://doi.org/10.1016/j.jinf.2020.04.002">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2895 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7195072">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d11369e2905 class=n-a></a>Zuo Y, Yalavarthi S, Shi H, <i> et al.</i>: Neutrophil extracellular traps in COVID-19. <i>JCI Insight.</i> 2020; <b>5</b>(11): 138999. <a target=xrefwindow id=d11369e2916 href="http://www.ncbi.nlm.nih.gov/pubmed/32329756">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2919 href="https://doi.org/10.1172/jci.insight.138999">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d11369e2928 class=n-a></a>Sawalha AH, Zhao M, Coit P, <i> et al.</i>: Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. <i>Clin Immunol.</i> 2020; <b>215</b>: 108410. <a target=xrefwindow id=d11369e2939 href="http://www.ncbi.nlm.nih.gov/pubmed/32276140">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2942 href="https://doi.org/10.1016/j.clim.2020.108410">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2946 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7139239">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d11369e2955 class=n-a></a>McGonagle D, O'Donnell JS, Sharif K, <i> et al.</i>: Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. <i>Lancet Rheumatol.</i> 2020. <a target=xrefwindow id=d11369e2963 href="https://doi.org/10.1016/S2665-9913(20)30121-1">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d11369e2972 class=n-a></a>Wang Y, Zhang D, Du G, <i> et al.</i>: Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial. <i>Lancet.</i> 2020; <b>395</b>(10236): 1569–78. <a target=xrefwindow id=d11369e2983 href="http://www.ncbi.nlm.nih.gov/pubmed/32423584">PubMed Abstract </a> | <a target=xrefwindow id=d11369e2986 href="https://doi.org/10.1016/S0140-6736(20)31022-9">Publisher Full Text </a> | <a target=xrefwindow id=d11369e2990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7190303">Free Full Text </a></span><div class=note><a name=d11369e2992 class=n-a></a><p class=first id=d11369e2993><a target=xrefwindow href="https://facultyopinions.com/prime/737842320" id=d11369e2994>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d11369e3003 class=n-a></a>Tang W, Cao Z, Han M, <i> et al.</i>: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: Open label, randomised controlled trial. <i>BMJ.</i> 2020; <b>369</b>: m1849. <a target=xrefwindow id=d11369e3014 href="http://www.ncbi.nlm.nih.gov/pubmed/32409561">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3017 href="https://doi.org/10.1136/bmj.m1849">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3021 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7221473">Free Full Text </a></span><div class=note><a name=d11369e3023 class=n-a></a><p class=first id=d11369e3024><a target=xrefwindow href="https://facultyopinions.com/prime/737950710" id=d11369e3025>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d11369e3034 class=n-a></a>Cao B, Wang Y, Wen D, <i> et al.</i>: A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. <i>N Engl J Med.</i> 2020; <b>382</b>(19): 1787–99. <a target=xrefwindow id=d11369e3045 href="http://www.ncbi.nlm.nih.gov/pubmed/32187464">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3048 href="https://doi.org/10.1056/NEJMoa2001282">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3052 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7121492">Free Full Text </a></span><div class=note><a name=d11369e3054 class=n-a></a><p class=first id=d11369e3055><a target=xrefwindow href="https://facultyopinions.com/prime/737578995" id=d11369e3056>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d11369e3066 class=n-a></a>Cai Q, Yang M, Liu D, <i> et al.</i>: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. <i>Engineering (Beijing).</i> 2020. <a target=xrefwindow id=d11369e3074 href="http://www.ncbi.nlm.nih.gov/pubmed/32346491">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3077 href="https://doi.org/10.1016/j.eng.2020.03.007">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3080 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7185795">Free Full Text </a></span><div class=note><a name=d11369e3082 class=n-a></a><p class=first id=d11369e3083><a target=xrefwindow href="https://facultyopinions.com/prime/737589209" id=d11369e3084>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d11369e3093 class=n-a></a>Xu X, Han M, Li T, <i> et al.</i>: Effective treatment of severe COVID-19 patients with tocilizumab. <i>Proc Natl Acad Sci U S A.</i> 2020; <b>117</b>(20): 10970–5. <a target=xrefwindow id=d11369e3104 href="http://www.ncbi.nlm.nih.gov/pubmed/32350134">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3107 href="https://doi.org/ 10.1073/pnas.2005615117">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3111 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7245089">Free Full Text </a></span><div class=note><a name=d11369e3113 class=n-a></a><p class=first id=d11369e3114><a target=xrefwindow href="https://facultyopinions.com/prime/737846545" id=d11369e3115>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d11369e3124 class=n-a></a>Mazzitelli M, Arrighi E, Serapide F, <i> et al.</i>: Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia. <i>J Med Virol.</i> 2020. <a target=xrefwindow id=d11369e3132 href="http://www.ncbi.nlm.nih.gov/pubmed/32410234">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3135 href="https://doi.org/10.1002/jmv.26016">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3138 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7272953">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d11369e3147 class=n-a></a>Cavalli G, de Luca G, Campochiaro C, <i> et al.</i>: Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: A retrospective cohort study. <i>Lancet Rheumatol.</i> 2020; <b>2</b>(6): e325–e331. <a target=xrefwindow id=d11369e3158 href="http://www.ncbi.nlm.nih.gov/pubmed/32501454">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3161 href="https://doi.org/10.1016/S2665-9913(20)30127-2">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3165 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7252085">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d11369e3174 class=n-a></a>Hung IFN, Lung KC, Tso EYK, <i> et al.</i>: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial. <i>Lancet.</i> 2020; <b>395</b>(10238): 1695–1704. <a target=xrefwindow id=d11369e3185 href="http://www.ncbi.nlm.nih.gov/pubmed/32401715">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3188 href="https://doi.org/10.1016/S0140-6736(20)31042-4">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3192 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7211500">Free Full Text </a></span><div class=note><a name=d11369e3194 class=n-a></a><p class=first id=d11369e3195><a target=xrefwindow href="https://facultyopinions.com/prime/737927203" id=d11369e3196>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d11369e3205 class=n-a></a>Cantini F, Niccoli L, Matarrese D, <i> et al.</i>: Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact. <i>J Infect.</i> 2020; S0163-4453(20)30228-0. <a target=xrefwindow id=d11369e3213 href="http://www.ncbi.nlm.nih.gov/pubmed/32333918">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3216 href="https://doi.org/10.1016/j.jinf.2020.04.017">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3219 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7177073">Free Full Text </a></span><div class=note><a name=d11369e3221 class=n-a></a><p class=first id=d11369e3222><a target=xrefwindow href="https://facultyopinions.com/prime/737822628" id=d11369e3223>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d11369e3233 class=n-a></a>Duan K, Liu B, Li C, <i> et al.</i>: Effectiveness of convalescent plasma therapy in severe COVID-19 patients. <i>Proc Natl Acad Sci U S A.</i> 2020; <b>117</b>(17): 9490–6. <a target=xrefwindow id=d11369e3244 href="http://www.ncbi.nlm.nih.gov/pubmed/32253318">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3247 href="https://doi.org/10.1073/pnas.2004168117">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3251 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7196837">Free Full Text </a></span><div class=note><a name=d11369e3253 class=n-a></a><p class=first id=d11369e3254><a target=xrefwindow href="https://facultyopinions.com/prime/737695760" id=d11369e3255>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d11369e3264 class=n-a></a>Zhu FC, Li YH, Guan XH, <i> et al.</i>: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial. <i>Lancet.</i> 2020; <b>395</b>(10240): 1845–1854. <a target=xrefwindow id=d11369e3275 href="http://www.ncbi.nlm.nih.gov/pubmed/32450106">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3278 href="https://doi.org/10.1016/S0140-6736(20)31208-3">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3282 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7255193">Free Full Text </a></span><div class=note><a name=d11369e3284 class=n-a></a><p class=first id=d11369e3285><a target=xrefwindow href="https://facultyopinions.com/prime/737996406" id=d11369e3286>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d11369e3295 class=n-a></a>Zhou Y, Hou Y, Shen J, <i> et al.</i>: Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. <i>Cell Discov.</i> 2020; <b>6</b>: 14. <a target=xrefwindow id=d11369e3306 href="http://www.ncbi.nlm.nih.gov/pubmed/32194980">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3309 href="https://doi.org/10.1038/s41421-020-0153-3">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7073332">Free Full Text </a></span><div class=note><a name=d11369e3315 class=n-a></a><p class=first id=d11369e3316><a target=xrefwindow href="https://facultyopinions.com/prime/737556823" id=d11369e3317>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d11369e3326 class=n-a></a>Wang M, Cao R, Zhang L, <i> et al.</i>: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. <i>Cell Res.</i> 2020; <b>30</b>(3): 269–71. <a target=xrefwindow id=d11369e3337 href="http://www.ncbi.nlm.nih.gov/pubmed/32020029">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3340 href="https://doi.org/10.1038/s41422-020-0282-0">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3344 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7054408">Free Full Text </a></span><div class=note><a name=d11369e3346 class=n-a></a><p class=first id=d11369e3347><a target=xrefwindow href="https://facultyopinions.com/prime/737311964" id=d11369e3348>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d11369e3357 class=n-a></a>Agostini ML, Andres EL, Sims AC, <i> et al.</i>: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. <i>mBio.</i> 2018; <b>9</b>(2): 1953. <a target=xrefwindow id=d11369e3368 href="http://www.ncbi.nlm.nih.gov/pubmed/29511076">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3371 href="https://doi.org/ 10.1128/mBio.00221-18">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3375 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5844999">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d11369e3384 class=n-a></a>Savarino A, Di Trani L, Donatelli I, <i> et al.</i>: New insights into the antiviral effects of chloroquine. <i>Lancet Infect Dis.</i> 2006; <b>6</b>(2): 67–9. <a target=xrefwindow id=d11369e3395 href="http://www.ncbi.nlm.nih.gov/pubmed/16439323">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3398 href="https://doi.org/10.1016/S1473-3099(06)70361-9">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3402 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7129107">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d11369e3412 class=n-a></a>Vincent MJ, Bergeron E, Benjannet S, <i> et al.</i>: Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. <i>Virol J.</i> 2005; <b>2</b>: 69. <a target=xrefwindow id=d11369e3423 href="http://www.ncbi.nlm.nih.gov/pubmed/16115318">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3426 href="https://doi.org/10.1186/1743-422X-2-69">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3430 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1232869">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d11369e3439 class=n-a></a>Liu J, Cao R, Xu M, <i> et al.</i>: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection <i>in vitro</i>. <i>Cell Discov.</i> 2020; <b>6</b>: 16. <a target=xrefwindow id=d11369e3453 href="http://www.ncbi.nlm.nih.gov/pubmed/32194981">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3457 href="https://doi.org/10.1038/s41421-020-0156-0">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3460 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7078228">Free Full Text </a></span><div class=note><a name=d11369e3462 class=n-a></a><p class=first id=d11369e3463><a target=xrefwindow href="https://facultyopinions.com/prime/737576290" id=d11369e3464>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d11369e3473 class=n-a></a>Gautret P, Lagier JC, Parola P, <i> et al.</i>: Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. <i>Int J Antimicrob Agents.</i> 2020; 105949. <a target=xrefwindow id=d11369e3481 href="http://www.ncbi.nlm.nih.gov/pubmed/32205204">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3484 href="https://doi.org/10.1016/j.ijantimicag.2020.105949">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3487 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7102549">Free Full Text </a></span><div class=note><a name=d11369e3489 class=n-a></a><p class=first id=d11369e3490><a target=xrefwindow href="https://facultyopinions.com/prime/737589198" id=d11369e3491>Faculty Opinions Recommendation</a></p></div></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d11369e3500 class=n-a></a>Chu CM, Cheng VCC, Hung IFN, <i> et al.</i>: Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. <i>Thorax.</i> 2004; <b>59</b>(3): 252–6. <a target=xrefwindow id=d11369e3511 href="http://www.ncbi.nlm.nih.gov/pubmed/14985565">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3514 href="https://doi.org/10.1136/thorax.2003.012658">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3518 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1746980">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d11369e3527 class=n-a></a>Du YX, Chen XP: Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection. <i>Clin Pharmacol Ther.</i> 2020. <a target=xrefwindow id=d11369e3532 href="http://www.ncbi.nlm.nih.gov/pubmed/32246834">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3535 href="https://doi.org/10.1002/cpt.1844">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d11369e3544 class=n-a></a>Cavalli G, Dinarello CA: Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. <i>Rheumatology (Oxford).</i> 2015; <b>54</b>(12): 2134–44. <a target=xrefwindow id=d11369e3552 href="http://www.ncbi.nlm.nih.gov/pubmed/26209330">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3555 href="https://doi.org/10.1093/rheumatology/kev269">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3558 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5009422">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d11369e3568 class=n-a></a>Bechman K, Subesinghe S, Norton S, <i> et al.</i>: A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis. <i>Rheumatology (Oxford).</i> 2019; <b>58</b>(10): 1755–66. <a target=xrefwindow id=d11369e3579 href="http://www.ncbi.nlm.nih.gov/pubmed/30982883">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3582 href="https://doi.org/10.1093/rheumatology/kez087">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d11369e3591 class=n-a></a>Xun J, Lu L, Jiang S, <i> et al.</i>: Patient Cohort and Their Implications. <i>medRxiv.</i> 2020. </span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d11369e3606 class=n-a></a>Thanh Le T, Andreadakis Z, Kumar A, <i> et al.</i>: The COVID-19 vaccine development landscape. <i>Nat Rev Drug Discov.</i> 2020; <b>19</b>(5): 305–6. <a target=xrefwindow id=d11369e3617 href="http://www.ncbi.nlm.nih.gov/pubmed/32273591">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3620 href="https://doi.org/10.1038/d41573-020-00073-5">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d11369e3629 class=n-a></a>Coronavirus R, Ag C, Company T, <i> et al.</i>: CureVac ´ s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate. 2020. <a target=xrefwindow id=d11369e3634 href="https://www.curevac.com/news/curevac-s-optimized-mrna-platform-provides-positive-pre-clinical-results-at-low-dose-for-coronavirus-vaccine-candidate">Reference Source</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d11369e3643 class=n-a></a>Amanat F, Krammer F: SARS-CoV-2 Vaccines: Status Report. <i>Immunity.</i> 2020; <b>52</b>(4): 583–9. <a target=xrefwindow id=d11369e3651 href="http://www.ncbi.nlm.nih.gov/pubmed/32259480">PubMed Abstract </a> | <a target=xrefwindow id=d11369e3654 href="https://doi.org/10.1016/j.immuni.2020.03.007">Publisher Full Text </a> | <a target=xrefwindow id=d11369e3657 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7136867">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Jun 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-638/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-638/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> National Brain Research Centre, Manesar, Gurugram, Haryana, India<br/> <p> <div class=margin-bottom> Surajit Chakraborty <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Resources, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Anirban Basu <br/> <span>Roles: </span> Conceptualization, Investigation, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-638/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 23 Jun 2020, 9:638 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.24963.1">https://doi.org/10.12688/f1000research.24963.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Chakraborty S and Basu A. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=27540 data-id=24963 data-downloads="" data-views="" data-scholar="10.12688/f1000research.24963.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-638/v1/pdf?article_uuid=ed6ca138-9742-4ff5-a4a0-407ebe105c0a" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.24963.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Chakraborty S and Basu A. The COVID-19 pandemic: catching up with the cataclysm [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):638 (<a href="https://doi.org/10.12688/f1000research.24963.1" target=_blank>https://doi.org/10.12688/f1000research.24963.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=24963 id=mobile-track-article-signin-24963 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/24963?target=/articles/9-638/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27540 /> <input name=articleId type=hidden value=24963 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Branka Horvat</strong>, International Center for Infectiology Research-CIRI, ENS Lyon, France </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Arup Banerjee</strong>, Regional Centre for Biotechnology, India </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Jun 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-638/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-638/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=69708-65153></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=69709-65154></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-638/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>23 Jun 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Branka Horvat</strong>, International Center for Infectiology Research-CIRI, ENS Lyon, France </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Arup Banerjee</strong>, Regional Centre for Biotechnology, India </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-638/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-638/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The COVID-19 pandemic: catching up with the...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-638/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-638/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-638/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Chakraborty S and Basu A');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-638/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-638",
            templates : {
                twitter : "The COVID-19 pandemic: catching up with the cataclysm. Chakraborty S and Basu A, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-638/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The COVID-19 pandemic: catching up with the cataclysm", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The COVID-19 pandemic: catching up with the cataclysm", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/24963/27540")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "27540");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "65153": 1,
                           "65154": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "baaee2c4-f138-419e-a4f0-58b2ffc023bb";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-638.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-638.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-638.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-638.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-638.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>